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The rapid development in bio-nanotechnology coupled with advancements in 
microelectronics and computing power has given rise to an enormous potential for the 
development of point-of-care diagnostic devices and portable biosensors. The application area 
encompasses human disease detection, analyzing bio-hazardous molecules and toxins and 
other inorganic materials. Amongst the plethora of receptors in such biosensors, aptamers, 
which are oligonucleotides with high affinity for target analytes, have demonstrated 
considerably improved performance over traditional receptors like antibodies. The hallmark of 
a portable biosensor is high throughput in response to analyte characterized by appreciable 
signal/noise ratio, dynamic range and low limit of detection. However, these characteristics are 
difficult to achieve in practical scenarios due to a variety of factors and thus the success is 
mostly limited to lab based developments. Particularly, the poor commercial success of 
portable biosensors directed towards human disease detection is noticeable. 
In this study, effort has been made to address some of the issues like external control 
over target binding to receptor, low signal/noise ratio and detection in presence of interfering 
molecules, challenging the practical deployment of a portable aptamer-based biosensor by 
focusing on engineering of the nano-bio interface of the transducer in such devices. The 
investigation is carried out in three directions:  
1. Electrical actuation of receptor-target complex 
2. Impedance characterization of nanoporous transducer 




The goal of the present research is to provide improved understanding of such processes 
which can lead to the design and creation of a point-of-care diagnostic device with the ability 
to detect human disease markers like:  
(i) Ebola virus protein sGP/GP1-GP2 as a biomarker for Ebola virus infection 
(ii) NGAL protein related to Acute Kidney Injury 
Through the research described in this thesis, the following have been understood: 
(a) The actuation of aptamer-protein complex, where the protein may be 
dissociated from the aptamer immobilized on the electrode surface due to externally 
applied electric field depends on the length of the aptamer nucleotide sequence, charge of 
protein and the surface grafting density of aptamer. 
(b) Four-electrode electrochemical sensors, utilizing nanoporous alumina 
membrane with aptamer immobilized on one surface can be used as a biosensor in which 
membrane impedance depends on target concentration and greater sensitivity is observed 
with serum albumin in the sample to be tested. Also, there exists an optimal frequency for 
aptamer-protein complexes which can help in reducing the time of operation of such a 
biosensor by eliminating the need for long range of frequency scans to get system 
impedance. 
(c) Competition mode of sensing, using a receptor weakly attached to the surface 
via a linker, and having higher propensity to bind with target analyte in the solution 
compared to remaining surface bound, may be used as a technique to increase signal/noise 






CHAPTER 1.  GENERAL INTRODUCTION: RESEARCH PROBLEM 
 
1.1 Biosensors and State- of -the Art 
 
Biosensor is an analytical device that converts biological interactions into measurable 
physiochemical signals  proportional to analyte concentration. Biosensors can be used for the 
detection of various organic/inorganic materials like proteins, nucleic acids, metals, metabolites, 
pollutants, microbes/pathogens, viruses and toxins etc. According to the IUPAC definition, a 
biosensor is an integrated receptor-transducer device capable of providing selective quantitative 
or semi-quantitative analytical information using a biological recognition element. A typical 
biosensor thus consists of two elements: biological sensing/recognition element and a transducer 
for the detection of analyte concentration 1. The outline of a typical biosensor is given below: 
 
Figure 1.1 Schematic of a biosensor 
As depicted in fig.1, the analyte is the target molecule (e.g. protein) and the biological 
recognition element (e.g. nucleic acid) is surface assembled onto the transducer. The interaction 
between the analyte and the recognition element generates a physiochemical signal which is 




system in case of electrochemical biosensor). The detector is coupled to a display (e.g. a desktop 
computer or laptop/smartphone) for reading by the end user (e.g. healthcare professional/patient).  
The biosensor definition could also be applied to biomimetic recognition elements, like, 
‘‘mini-enzymes,’’ synzymes, aptamers, and molecularly imprinted polymers (MIPs), which are 
products of biological research. A robust recognition element can be spatially integrated with the 
transducer which in turn makes a compact functional unit that allows reuse of the biological 
component and miniaturization of the sensor body. These features allow for online measurements 
and are the basis of the combination of different recognition elements on one transducer array: the 
biochips. Integration of the biochemical mechanisms and transducer signal processing has been 
realized in ‘‘intelligent biosensors’’ giving rise to electrochemical sensors and bio-FETs. 
Leveraging unprecedented advances in micro/nanoelectronics, molecular biology and 
nanotechnology in general we can now make use of total microanalytical systems (µTAS), which 
are the lab-on-a-chip combination of biosensors with microfluidics and actuators. 
Leland C. Clarke is credited with the first use of the term “biosensor”, in 1962, when he 
demonstrated his pioneering work on a glucose oxidase based electrochemical sensor for the 
detection of glucose 1. In over 50 years since then, biosensors have evolved in different directions 
and presently the thrust is on point-of-care diagnostics and portable devices. With developments 
in nanotechnology in both the biological and electronic materials realm, the global biosensors 
market is poised to reach USD 27.06 billion by 2022 2. In spite of the large potential and the great 
expectations through the last 30 years, biosensors have found only limited application. The 
commercial sector is clearly dominated by the decentralized blood glucose measurement and the 




In the commercial arena, two of the most established biosensors are the portable glucose 
meters / glucometers (multiple brands like Abbott, Bayer, Medtronic etc.) and the Biacore 
(acquired by GE healthcare) system (figure 2). Almost all the current glucose meters utilized the 
electrochemical sensing method to detect glucose in whole blood by fundamentally employing the 
principle established by Clarke. On the other hand, the Biacore system is used to gather 
kinetic/thermodynamic information for protein-antibody interactions, based on surface plasmon 
resonance (SPR) technology and has established itself as a much sought-after tool in the 
pharmaceutical industry.  
1.2 Current Technologies and Needs of Improvement 
(a) ELISA based systems 
Commercial biosensing assays involve incubation with analyte solutions and measure 
enzyme activity like the widely popular enzyme-linked immunosorbent assay (ELISA) technique 
that operates by selective binding of analytes onto antibodies immobilized in microplate wells and 
monitors subsequent color variations resulting from enzymatic amplification reactions. ELISA is 
extremely versatile in clinical detection of viral antibodies. Electro-chemiluminescence 




immunoassays (ECLIA), is another widely used technique which uses two antibodies to sandwich 
the analyte in solution. Despite the effectiveness of the aforementioned chemical techniques, there 
are several practical limitations. The need for several reagents, labels which may interfere with 
antibody receptor, pre-assay purification, post-assay calibration and complex lab equipment are 
serious impediments for real-time high throughput, portability and on-site monitoring 3, 4. Portable 
ELISA devices are still under development, primarily in the academia. Still ELISA and its 
derivatives are the go-to detection platform for clinicians and physicians, because of a dearth of 
better alternatives available in the market. 
(b) Lateral flow assay (LFA) / Paper based biosensor 
The lateral flow assay (LFA) is a paper-based platform 5 for the detection and 
quantification of analytes in complex mixtures, where the sample is placed on a test device and 
the results are displayed within 5–30 min. Most of the LFAs utilize antibodies as recognition 
elements and some use nucleic acids to detect PCR products. The LFA device is primarily 
qualitative and provides confirmation of target analyte through visual detection. One of the most 
popular LFA available for general public use is the pregnancy test kit which can cost as low as $4.  
Quantitative determination of analytes is possible by coupling other technologies 
(predominantly optical) like chemiluminescence with LFA, which increases the device cost 
substantially. LFAs have the advantage of better sample handling due to the preprocessing step 
involving a membrane which screens out many interfering molecules including blood cells. 




Recently, paper based devices have found great attention resulting in rapid development due to the 
promise of cheap and easy to use devices 6. Unfortunately, the results from these studies are 
generally qualitative or semi-quantitative 7, 8. There are some glaring limitations 7, 9 which preclude 
the proliferation of paper based LFAs for disease detection : (i) inefficient sample flow through 
the devices (ii) inadequacy of fabrication methodologies (iii) performance parameters  
(c) Surface Plasmon Resonance (SPR) systems – label free 
SPR operates via an optical detection scheme wherein the change in refractive index of the 
transducer platform is correlated to the analyte concentration upon interaction. SPR signal is 
associated with an energy minimum in reflected light and this signal changes angle as analyte mass 
binds and dissociates from the transducer surface 10, 11. This angle shift can be monitored over time 
and provides the user with relevant kinetic parameter. SPR is label free and commercial equipment 
can process 5000+ reactions in 24 hours making it an essential equipment in the pharmaceutical 
industry. Major manufacturers are GE Healthcare, Bio-Rad Laboratories, Biosensing Instruments, 
Horiba and Reichert Technologies. However, the cost ( e.g. Biacore costs more than $100,000 and 
3 chips come for ~ $1000) and complex instrumentation involved precludes the proliferation of 
SPR based systems in the point of care diagnostics market 12. Still a lot of effort is being made to 
develop low cost portable SPR biosensors 13. 
(d) Bio Layer Interferometry (BLI) systems – label free 
In BLI, the tip of a fiber-optic probe is coated with receptor and acts as the biosensor. The 
probe can be inserted into a multi-well plate containing analyte solution. White light is used to 
read the assay. Interference between light reflecting off the reference and immobilized surfaces of 
the tip creates a distinctive pattern of light returning up the fiber. As molecules bind to the 




Bio (now Danaher) is the leading player for this technology in North America. The price range is 
$50,000-$200,000 and the main user is the pharmaceutical industry. 
(e) Other optical systems 
Corning's Epic technology relies on the ability of specially patterned surfaces to reflect 
distinct wavelengths selectively when illuminated with broadband light. Perkin-Elmer uses this 
platform in their Enspire Multi Mode Plate Reader which supports both cell based and biochemical 
assays. This system is mainly used in the pharmaceutical industry and costs upwards of $100,000.  
Surface enhanced Raman scattering (SERS) has several advantages over conventional 
techniques. Multiplexing capabilities of SERS readout is a very attractive feature and there has 
been several publications in this field. Still, there are several impediments to the development of 
portable low cost SERS biosensor, one of them being the portability and possibility of a cheap 
optical component. 
(f) Quartz Crystal Microbalance (QCM) based systems 
QCM biosensors are being developed in conjunction with SPR based techniques to 
improve the detection limit in complex matrices 14. In QCM, the resonant frequency of the new 
mass attached to the transducer due to the binding of target is analyzed. The typical cost of such a 
device could be anywhere between $ 15,000 – 30,000 , however, QCM based techniques have 
shown great promise in detecting target analytes in complex medium. 
(g) Surface acoustic wave (SAW) sensors 
SAW based sensors have great promise and some of the devices have undergone trial in 
the market 15. They show great promise in the detection of small molecules / gaseous substances, 





 (h) Micro-cantilever (MC) sensors 
There have been two separate types of MC sensors – optical and piezoelectric. In the MC 
sensor, the change in thin film surface stress due to the binding of target analyte with the receptor 
functionalized micro-cantilever is monitored. These sensors can detect very low (pM to nM) 
analyte concentrations without the need of labels 16-18. However, they are yet to attain commercial 
success primarily due to the difficulty in miniaturizing the optical/piezoelectric paraphernalia 
needed in portable devices and isolating vibration and other environmental noise. 
Biosensor technologies based on the direct combination of recognition elements and 
reporter molecules capable of on spot transduction of analyte detection events are far more useful 
and efficient in terms of practical applications.  
There is an increasing demand for biosensors in point-of-care-diagnostics serving critical 
areas like human disease detection, wellness, biodefense etc. Still there is limited 
commercial/practical success even after decades of widespread research activities. The most 
common issues faced by biosensors are the detection of desired low concentration analyte in 
presence of interfering substances in the sample, reusability with reproducible results and stability 
of the recognition element in case of prolonged storage/usage of the sensor. In spite of this, with 
recent advances in the field of bio-nanotechnology, bio-electronics and smart/wearable devices, 
considerable efforts have been made across the world for the creation of robust as well as portable 
biosensors 4. 
1.3 Electrochemical Biosensors – Advantages Exceed Shortcomings 
As evident from the commercial success of the glucose sensor, electrochemical biosensors 
possess the advantage of simple sensor design and low manufacturing cost. This is possible due to 
the implementation of low-cost microelectronic circuits and convenient interfacing with normal 




their robustness, easy miniaturization, excellent detection limits and ability to handle small analyte 
volumes 1, 4.  
In the area of clinical diagnostics, high sensing throughput is of paramount importance and 
electrochemical biosensors face stiff competition from chromatography based analytical chemistry 
methods and HPLC-MS systems 19. Still, affinity based biosensors like electrochemical biosensors, 
have an edge over traditional analytical techniques on throughput rate as the molecular interaction 
between receptor and analyte can be transduced to detectable signals in fast manner. Particularly, 
electrochemical sensors employing field-effect transistors 20 and nanopores 21 have been 
demonstrated to detect viruses and proteins in lab environments. The current deficiency in lack of 
automation and extra time in regeneration of sensing surface can be mitigated through the 
application of microfluidics and multiplexing offered by rapid advancements in nanotechnology 
in the last decade. Thus electrochemical sensors have high potential to outcompete traditional 
methods in the near future 4. 
Another constraint for electrochemical biosensors is the inability to not have a linear 
response to cover the full range of relevant levels of the analyte. This is because, inherently affinity 
based sensors are limited by binding kinetics. For e.g., there is a set span of target analyte 
concentration of 81-fold between 90% receptor occupancy and 10% receptor occupancy centered 
at the dissociation constant KD (concentration of analyte that yields 50% receptor occupancy at 
equilibrium). Consequently, for a single type receptor-analyte binding based biosensor, the 
dynamic range is limited to roughly 2 orders of magnitude without even considering interference 
due to non-specific binding. In contrast, it is not unusual for protein biomarkers to exhibit 
concentration variations of more than 3 orders of magnitude. Interestingly, it could be possible to 




bioengineered to have the same specificity but with varying binding affinities, and therefore, 
several different recognition units with appropriately spaced KD values can be utilized in order to 
significantly extend the linear response regime of the sensor under certain conditions up to 5 orders 
of magnitude 4, 22. 
Further interesting mention would be the comparison of electrochemical biosensors with 
that of SPR biosensors, both of which employ affinity based techniques. There are several 
instances of portable SPR biosensors, however almost all of these are not directed towards the 
detection of disease biomarkers in serum, plasma or blood, wherein there are numerous instances 
of lab based electrochemical biosensors for detecting disease biomarkers in body fluids. Also, the 
paraphernalia of SPR biosensors involves light source, spectrometer and other bulkier equipment 
compared to the potential development of low cost chip based electrochemical biosensors 
facilitated by the miniaturization of potentiostat and advances in microelectronics. The variety of 
nanomaterials like graphene, nanoporous alumina, MoS2 etc. offer a plethora of material choices 
for transducer platforms. 
Figures 1.4 and 1.5 show some of the portable/miniaturized SPR and electrochemical 
sensors. 
 





 Thus, there are several areas demanding considerable improvement, which preclude the 
commercial success of electrochemical biosensors in areas other than glucose or lactate 
detection. Electrochemical biosensors have suffered from a lack of surface architectures allowing 
high enough sensitivity and unique identification of the response due to the desired biochemical 
event 25. For example, pH and ionic strength in the sample can differ significantly from the ideal 
condition, which affects the response by causing structural changes in the recognition element.  
In this study, certain aspects of the development of an electrochemical sensor towards the 
development of portable diagnostic devices has been discussed in the following section. The focus 
is on investigation of these aspects to create a portable device which can be used in various 
scenarios for the detection of target analytes, by conveniently changing the recognition element. 
This process by which a technology is built into an integrated instrument demands a detailed and 
Figure 1.5: Point-of-care electrochemical biosensors; (a) (i) pocket sized commercial 
potentiostat (IVIUM) (ii) DropStat (DropSens) (iii) EmStat (PalmSens) (b) Smartphone 





thorough consideration of the many factors that contribute to its performance. The present study 
aims to identify some of these key areas and address them through the development of new 
processes. 
1.4 Research Focus – Engineering of Transducer in Electrochemical Aptasensor 
 
For rapid diagnosis of debilitating health conditions, high mortality infectious diseases and 
monitoring of chronic ailments, there is a growing impetus in the development of portable 
biological sensing technology. An increased focus in industry and specially in academia is to 
implement cheap and point-of-care solutions targeted towards population in developed as well as 
developing nations. Still, there is no concrete solutions or a single platform which can 
accommodate all the desired functionalities and be user friendly at the same time. Hence, in the 
market there are a plethora of products and biosensor development has become a hot field of 
research. With advances in bio-nanotechnology, microelectronics and the big data / smartphone 
revolution the area of portable diagnostics has never looked brighter. 
As portrayed in the previous section, one of the most important problem is improvement 
of the selectivity and sensitivity of an electrochemical biosensor. The synthesis of a suitable 
recognition element is more in the realms of molecular biology. From the viewpoint of mechanical 
engineering, a relevant focus area is investigating the role of the transducer. This study is aimed at 
the development of protein sensors. Nucleic acids have been shown to selectively bind with 
specific proteins. Aptamers are short oligonucleotides which are synthesized through a process 
called SELEX for binding specifically with target proteins 26. Aptamers display similar specific 
affinity for their target analyte as antibodies do and have the following additional advantages over 
antibodies for application to analytical platforms: stable over a larger range of temperatures and 




applications 27. Aptamer based biosensors are also termed as aptasensors. Throughout this study 
aptamers have been used as the recognition element. For e.g. thrombin binding aptamer, consisting 
of the consensus sequence GGTTGGTGTGGTTGG, has been used to quantitatively detect human 
alpha thrombin 28. This aptamer is functionalized on a suitable transducer surface for use in an 
electrochemical biosensor developed for thrombin detection. 
To classify the research described in this thesis, three broad classifications can be made as 
shown in figure 5, wherein the nano-bio interface formed by the aptamer and the transducer is 
examined for developing biosensors with enhanced sensitivity and selectivity: 
1.5 Organization of the Thesis 
The thesis has been partitioned into chapters which are modified from submitted journal 
articles / working papers and the discussed research topics can be summarized as follows : 
(A) Electrical actuation of recognition element – described in chapter 2 
(B) Impedance modulation of nano-bio interface of transducer – described in chapter 3 
(C) Engineering of SAM in the recognition element – described in chapter 4 
(D) Applications of an impedance based aptasensor – described in chapter 5 
(E) Future Work : Smart, portable biosensors – described in chapter 6 




The following sections elaborates on these different chapters individually. 
1.5.1 Electrical Actuation of Recognition Element 
The current state of the art nanoscale devices for the modulation of biological response 
demand sensitive and controllable transmission of external stimuli to biological systems. 
Electrostatic actuation for the controlled release/capture of biomolecules through conformational 
transformations of bioreceptors provides an efficient and feasible mechanism to modulate 
biological response. In addition, electrostatic actuation mechanism has the advantage of allowing 
massively parallel schemes and measurement capabilities that could ultimately be essential for 
biomedical applications. Recent experiments and computational analysis have shown the 
unbinding of thrombin from its aptamer in presence of small positive electrode potential whereas 
the complex remained associated in presence of small negative potentials / zero potential 29, 30. In 
chapter 2, the effect of electric field on the aptamer-thrombin complex is characterized through 
electrochemical dynamic force spectroscopy and computational modeling to calculate the 
dependency of unbinding force on externally applied potentials. This work provides a 
comprehensive understanding of the electrically actuated binding/unbinding process which can 
have one possible application in electrochemical biosensors during sample regeneration phase by 
dislodging any bound target protein. Sensing surfaces based on these aptamers could be electrically 
regenerated multiple times with minimum effort 4. Also, electrical modulation of biomolecules 
structure and function may have far reaching implications in the development of responsive 
surfaces, switches and gates which can further enhance “smart and intelligent biosensors”. 
1.5.2 Impedance Modulation of Nano-bio Interface of Transducer 
Nanoporous anodized alumina or aluminum oxide membranes (NAAO) have great 
potential31 in bio-sensing devices through miniaturization and integration into lab-on-chip and 




sensing32, 33, detection of bacteria34, 35, antibody36 and protein sensing37. Label free biosensing 
techniques involve detection of target-probe binding in real time and thus can provide information 
on binding kinetics, association/dissociation rates and constants as well as facilitate increase in 
measurement accuracy through determination of binding/unbinding events. Particularly label free 
electrochemical impedance spectroscopy (EIS) based characterization techniques25 offer greater 
flexibility in the incorporation of NAAO bio-sensing platforms as transducers into existing 
detection schemes and could provide the realization of parallel assays. The issue of selective 
detection is of paramount importance for a bio-sensor devised for real-world application where the 
target concentration can be much less than the concentration of nontarget biomolecules. This 
demands a thorough consideration in improving the efficacy of such sensors.  
In chapter 3 the sensitive label free detection of human α-thrombin towards an aptamer 
modified NAAO is discussed. Under physiological conditions in human blood, α-thrombin can 
range from a few nanomolar (resting blood) to a few hundred nanomolar (when the clotting 
cascade is activated)38. The sensitivity of the proposed sensor was rigorously investigated for 
physiologically relevant α-thrombin concentrations in presence of a high background of 500 µM 
human serum albumin (HSA) (physiological concentration ~ 500-700 µM 39). 
1.5.3 Engineering of SAM of Recognition Element – Competition Sensing 
Unlabeled DNA and protein targets can be detected by monitoring changes in the 
impedance of the sensing surface, when a target molecule binds to an immobilized probe i.e. the 
recognition element or receptor. The sensor response is proportional to the number of target 
molecules bound to the receptor modified surface.  In complex matrices such as biological fluids, 
the sensor response is proportional to both the specific binding of analyte molecules to the 
receptors (desired signal) as well as non-specific binding of interfering molecules (noise) on the 




parameters: 1) the specific binding affinity between the analyte and receptor molecules; and 2) the 
sensor sensitivity for analyte-receptor complexes over nonspecifically binding molecules.  
In chapter 4, a description for a novel sensing approach for target detection in solution that 
can overcome the limitations in specificity due to a lack of sensitive discrimination between 
specific binding of target analyte and non-specific binding of interfering molecules has been 
provided. The sensing strategy involves functionalizing the sensing surface with receptor 
molecules with a reversible bond such that receptor molecules can be released from the surfaces 
on exposure to the target in solution. Thrombin and its specifically binding aptamer are used as 
ligand/receptor pair in the sensing experiments. Thrombin aptamers are first immobilized on the 
sensing surface (gold coated glass slide) using a reversible bond and the functionalized surface is 
exposed to free alpha thrombin in solution. Electrochemical impedance spectroscopy (EIS) is used 
to monitor the changes in aptamer surface coverage and thus determine the rate of receptor release 
in presence of thrombin molecules. As a negative control, functionalized surface was also exposed 
to gamma thrombin as it is structurally similar to alpha thrombin. Experimental results indicate 
that aptamer release rate is strongly dependent on specifically binding thrombin concentration 
while it is independent of the non-specifically binding gamma thrombin. In comparison to 
conventional sensing approaches, this competition sensing shows improvement in dynamic range 
followed by better sensitivity and specificity. 
1.5.4 Applications of An Impedance Based Aptasensor 
The aptasensor described in chapter 3 is modified to quantitively recognize certain 
biomarkers associated with the detection of Ebola virus infection 41, 42 and diagnosis of Acute 
Kidney Injury (AKI) 43-45. A detailed discussion is made in Chapter 5 with focus on sensor design 




1.5.5 Smart Portable Biosensors 
In chapter 6, a brief overview of the development of portable impedance analyzer is given 
as a future direction of the biosensor development project along with the summarizing conclusions. 
1.6 Contribution to Thesis Work 
The contribution of Agnivo Gosai ( AG., author of this thesis ) to the work described in the 
different chapters is laid out as follows : 
Chapter 2 : A.G. conducted the theoretical analysis described in the paper. The project was 
conceived by P.S., X.M and A.G. 
Chapter 3 : A.G. planned the experiments and conducted those with B.Y. A.G. analyzed 
the data and drew the conclusions. P.S. and A.G. conceived the project. 
Chapter 4 : A.G. planned and conducted the electrochemical experiments and analyzed the 
data using the theoretical model. P.S. conceived the project. 
Chapter 5 : A.G planned all the experiments and conducted the majority of those described 
in the study. In four experiments S.D, C.G and S.B. assisted A.G. A.G. analyzed the data and drew 
the conclusions for all the experiments. The aptamers used were developed by S.B., M.I. and C.G. 
The project was conceived by A.G., P.S. and M.N.H. 
Chapter 6 : A.G. planned the project of portable impedance analyzer and K.V. implemented 
the circuit and conducted the experiments with A.G. A.G conducted the analysis for optimal 
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2.1 Abstract 
Experimental and computational approaches are utilized to investigate the 
influence of electrostatic fields on the binding force between human thrombin and a 
thrombin binding DNA aptamer.  The thiolated aptamer was deposited onto gold substrate 
located in a liquid cell, and then repeatedly brought into contact with a thrombin-coated 
AFM tip under 0 mV, (+)100 mV and (-)100 mV electric fields respectively. Force drop-
offs during the pull-off process were measured to determine the unbinding force between 
the pair with loading rates spanning from 100 pN/s to 40000 pN/s. The results from 
experiments show that the specific binding events of the pair are drastically reduced under 
the positive electric fields. There is no influence on the molecular binding by negative 
electric fields. We also use a theoretical analysis to quantify the influence of the 
electrostatic force on a single thrombin molecule inside the complex of thrombin and 
aptamer and find good agreement with the experiments. The study confirms that 
electrostatic modulation of the binding interaction between thrombin and DNA aptamer is 
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possible and proposes a potential application in the field of biotic-abiotic interface 
manipulation.  
Keywords: Atomic force microscopy, Dynamic force spectroscopy, Thrombin-Aptamer, 
Electrostatic actuation 
2.2 Introduction 
The successful actuation and modulation of the binding behavior between the blood 
coagulation protein thrombin and its ss (single strand) DNA aptamer, has been 
demonstrated previously. However, the dynamic response and associated force interaction 
could not be characterized by those studies 1, 2. It should be noticed that explicit 
measurement and characterization of the binding force between thrombin-aptamer 
complex and unveiling of the underlying kinetics which governs the molecular binding 
physics could reveal in-depth information and insights on the electrostatic actuation based 
modulation of the conformation and binding behavior of biomolecules. This can provide 
an important insight into aptamer/target binding and unbinding for biosensor development 
and biotic-abiotic interface design 3, 4.  
Electrochemical atomic force microscopy (ECAFM) technology has been 
previously utilized to study the influence of electric fields on the physical and chemical 
properties of target surface. Boussaad et al. 5 utilized electrochemical tapping-mode AFM 
to study the interaction between myoglobin (Mb) and self-assembled di-dodecyl-dimethyl-
ammonium bromide (DDAB) mono- and multilayers. They discovered the heme group of 
the protein undergoes a fast electron-transfer reaction, and the structure of DDAB film has 
a potential dependence that it is changed from a solid like phase to liquid like phase with 
change of potentials from (-) 0.2V to (+) 0.2V. Kueng et al. 6, 7 developed a new technique 




simultaneous monitoring and investigation of surface topography and the enzyme activity 
of bioactive probes under electrostatic field application. Ciorcea et al. 8 utilized ECAFM 
to investigate the adsorption behavior of guanine on a highly oriented pyrolytic graphite 
(HOPG) electrode surface with controlled potentials from 0 to (+) 1.3V, and found the 
application of electric fields provided better attachment of the guanine on the HOPG 
surface compared to natural adsorption. Sekine et al. 9, 10 fabricated an AFM probe 
electrode by first insulating the probe with Parylene C, and then grounding the apex of the 
tip to expose the electrode. By in-situ topographical imaging of this ECAFM, on the 
heparin-coated substrate, under applied potentials from (+) 0.5V to (+) 1.5V, they observed 
the detachment of the heparin and the adsorption of fibronectin on the substrate. Hao et al. 
11 applied ECAFM to study the electrochemical behavior of the redox metallo-enzyme 
copper nitrite reductase (CNiR) immobilized on Au (111) surface under controlled 
potentials from (-) 0.2 V to (+) 0.2 V. They discovered a strong reductive electro-catalytic 
signal appeared in the presence of nitrite, which indicates the conformational changes in 
the enzyme upon substrate binding, and thus either enhanced the enzyme/electrode contact, 
or opened intramolecular electron-transfer channels between the redox center and the 
catalytic site. The ECAFM applications have also been utilized to study thin film growth 
and formation 12-24, deposition 25-32, dissolution 33-39, corrosion 40-44, phase transition 45, flux 
generation 46, and membrane proton conductivity 47. Besides, the development and 
improvement on the ECAFM technology itself has been carried on for simultaneous 
monitoring of electric field and topography imaging 48-54.   
In this study, we have conducted in-situ ECAFM based dynamic force spectroscopy 




determine the unbinding forces as a function of electrode potentials and corroborated the 
same with theoretical models. Using ECAFM we are able to show that the unbinding 
primarily depends on the interaction of charged biomolecules with the electric field of the 
environment. 
2.3 Methods 
2.3.1 Experimental techniques: 
5’ thiolated 50 nucleotide thrombin binding DNA aptamer (HS-GC CTT AAC TGT 
AGT ACT  GGT GAA ATT  GCT GCC ATT GGT TGG TGT GGT TGG) 55, was 
procured from IDT Technologies.  The boldface 15 nucleotide portion binds to the exosite-
I of human alpha thrombin. All chemicals and thrombin protein (human alpha thrombin) 
required for the experiments were purchased from Sigma Aldrich (www.sigma.com). 
Gold-coated silicon nitride micorcantilevers were purchased from Novascan Technologies 
Inc. (www.novascan.com). All solutions were prepared with deionized and distilled water 
(ddH2O). 
 Prior to thrombin functionalization, the spring constant of each AFM tip was 
determined via Sader’s method 56. Thrombin was then functionalized on the gold coated 
AFM tip using the following method: First, the probe was incubated in 2mM 
mercaptohexadecanoic acid (MHA) for 1 h to form a carboxyl-terminated self-assembled 
monolayer on the gold surface, then the probe was incubated in freshly prepared 10 mg/ml 
carbodiimide (EDAC) in ddH2O for 30 min to activate the carboxylic acid groups for 
protein attachment. The probe was then immersed in 10 μM human thrombin in phosphate 
saline solution (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 5 mM KH2PO4 in ddH2O 




carboxylic acid-terminated SAM surface. Finally, the probe was washed 3 times for 5 min 
each in buffered saline solution and 3 times for 5 min each in ddH2O. The probe was either 
used immediately or stored for less than 24 h in ddH2O before the experiments.  A single 
AFM tip was used to collect at the most 300 force curves and a total of 40 different AFM 
tips were used for the experiments. 
A template transfer technique was used to form a smooth gold film on polished 
silicon wafers. The aptamer-functionalized surfaces were prepared by immersion of gold 
coated silicon wafers in 3.4 μM thiolated aptamer in binding buffer (20 mM Tris-HCl, 140 
mM NaCl, 5 mM KCl, 1 mM CaCl2, 5 mM MgCl2, and 5% glycerol v/v in ddH2O at pH 
7.4) 57 for 1 min. The functionalized surfaces were rinsed several times with ddH2O and 
grounded with copper tape before being used for the unbinding experiments.  
Force curve experiments for coated substrates were performed in binding buffer 
using a Dimension 3100 atomic force microscope with a designed electrochemical cell, as 
shown in Fig. 1. During the experiments, the AFM tip was moved towards the sample to 





establish contact with surface and then retracted back to its starting location at a fixed 
displacement rate. Three electric fields strength of (-) 100mV, 0mV, (+) 100mV were 
applied onto the sample surface respectively using regular three electrode system. Open 
circuit force curve experiments were also conducted for comparison. The sample was the 
working electrode, while a silver wire was used as a reference electrode and platinum wire 
as a counter electrode. The force applied to the AFM tip during surface contact and 
retraction was measured to obtain the force curves. Loading rate dependence of the force 
interaction associated with each controlled potential was also considered by taking two 
different nominal displacement rates (200 nm/s and 2000 nm/s) of the AFM step motor. A 
total of two thousand force curves (20 samples × 10 locations/samples × 10 force 
curve/locations) were acquired for each displacement rate.  
2.3.2 Theoretical Analysis 
Polyelectrolyte brush theory is utilized to model single strand (ss) DNA at 
sufficiently high (~ 1012/nm2) electrode grafting densities, wherein, the DNA strands are 
assumed to form rod like structures. The charges due to the phosphate groups on the DNA 
bases are spaced in 0.34 nm intervals 58. For the continuum analysis the DNA aptamer layer 
is assumed to be in a 150 mM monovalent salt solution and we define a spatial direction z 
normal to the electrode surface (Figure 1(B)). The charge distribution in the DNA aptamer 
layer is approximated with charge density over the height of 35-mer linker (H1) assuming 
that the linker DNA chains are in straight conformation. While a higher charge density is 
utilized over the 15-mer (H2) aptamer sequence assuming that the aptamer strand is in 
G-quadruplex conformation resembling an armchair 59. The effect of linker DNA 
condensation or folding is approximated by assuming lower heights (fractions of H1) for 




the 15-mer part (1.6 nm), as derived from the structure in protein data bank (PDB 
entry148D) 59. Counterion condensation giving rise to renormalization of the backbone 
negative charges of the DNA is considered using Manning condensation theory 60.  
The charge density of the DNA is described by 
   𝜌𝐷𝑁𝐴 =  
𝑒𝜎𝑁𝑓
𝐻
𝜃(𝐻 − 𝑧); 𝜌𝑡ℎ𝑟𝑜𝑚𝑏𝑖𝑛 =  
6𝑒𝜎
𝑃
𝜃(𝑃 − 𝑧)                                                   (1) 
where, e is the electron charge, f the charging fraction calculated using Manning 
condensation theory, N the number of DNA bases, H the DNA layer height, P the protein 
length and θ is the Heaviside step function. The DNA sequence used in the experiments 
has, 35 nucleotides in the long tail (H1) and 15 nucleotides in the aptamer head (H2). The 
charging fraction is calculated as f = b/lB, where the Bjerrum length  lB = e
2/εkBT, where ε 
is relative permittivity of the medium, b the separation per charge, kB the Boltzmann 
constant and the temperature, T = 300K. For our system, b = 0.34 nm and lB ~ 0.7 nm, and 
hence f = 0.57. A 1 nm long (H0) charge neutral thiol linker molecule ( total DNA length 
H = H0 + H1 + H2) is also included in the model to mimic the thiol modification used to 
immobilize the aptamer with gold/thiol bond61. The charge for the thrombin protein is taken 
as (+) 6 e as per experimental reports62 and is modeled as smeared linearly over its length 
of 2.0 nm,1 in a similar fashion compared to that for the DNA.  
            The counterion charge density is given by a modified Poisson-Boltzmann 
equation described by  Borukhov et al. considering the finite size of ions 63: 
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where, Cbulk is the bulk counterion concentration, kB the Boltzmann constant, ψ the 
electrostatic potential of the system, ν the steric parameter limiting the ion concentration. 
ν = 2Cbulk × (ion radius)
3  63. The ion radius is 1.96 × 10-7 cm 58 . For the analysis counterions 
are excluded from the DNA layer as this provides the best agreement with experiments 58. 
We did not consider ion condensation for the protein charge also. Equations (1) and (2) are 
used in the Poisson-Boltzmann equation and non-dimensionalized to obtain the second 
order differential equation governing the system: 
∇2𝜓∗(𝑧∗) = 𝛽𝜃(𝐻∗ − 𝑧∗) + µ𝜃(𝑃∗ − 𝑧∗) +  
sinh (𝜓∗)
1+2𝜐𝑠𝑖𝑛ℎ2(𝜓∗/2)
𝜃(𝑧∗ − 𝐻∗)               (3)                                               
where ψ* is the nondimensional electrostatic potential, H*and P* the non- 
dimensional DNA layer height and thrombin protein length respectively. The electrostatic 
potential, ψ, and the spatial domain z, are non-dimensionalized by (kBT/e) and the Debye 
length 𝜆D = √(8πlBCbulk) respectively; the dimensionless coefficient β = Nf𝜎/2HCbulk and µ 
= 6𝜎/2PCbulk.  
Equation (3) is solved using MATLAB for boundary conditions of the external 
potential at electrode surface and zero electric field far away from the surface. The 
electrostatic potential distribution and the field thereof are computed for DNA layers with 
grafting densities varying from 𝜎 = 1011 cm-2 to 𝜎 = 1012 cm-2 , consistent with previous 
publications of our group 1, 2 and Stachowiak et al. 64 . The protein surface density is also 
matched equally to the DNA surface density 𝜎 considering 1:1 stoichiometry. Afterwards, 
the electrostatic force exerted on a single thrombin molecule, placed inside the thrombin 





2.4 Results and discussion 
2.4.1 Experimental observation 
The representative force curves of multiple unbinding events corresponding to 
interactions between thrombin coated AFM tip and aptamer functionalized surfaces under 
open circuit, (-)100 mV, 0 mV, and (+)100mV are shown in Fig.2.  
For 0mV and (-)100mV, force curves showed similar trend and magnitude as open 
circuit condition. While for (+)100mV, the magnitude of the last rupture force decreased, 
and the slope of the retraction curve had an abrupt change after the pull-up phase and the 
whole displacement is prolonged, which shows the substantial influence of electrostatic 
field application on the dissociation process. The percentage of force curves out of all 
attempts corresponding to no interaction, single unbinding and multiple unbinding events 
for all four situations are summarized in the Table 1. It indicated that for open circuit, 




(-) 100mV and 0mV, the multiple unbinding rates could always be held at around 10%, 
which is similar to observation reported in Pope. et al.’s studies on force-induced melting 
of 12mer double strand DNA65. However, for (+)100mV, the electrostatic field can reduce 
the multiple unbinding rate to one third level of the above cases. In other words, we can 
summarize that the positive electric field application can decrease both the binding strength 
and numbers of the thrombin-aptamer complex. 
Table 2.1: Summary of force curves under electric fields 
 No interaction Single unbinding 
Multiple 
unbinding 
Open circuit 14.9% 73.9% 11.2% 
(-)100mV 31.4% 59.5% 10.6% 
0mV 23.2% 66.3% 9.15% 
(+)100mV 56.0% 40.7% 3.35% 
 
The rupture force of the last step of multiple unbinding events was analyzed since 
it mostly likely approaches single bond dissociation, and the slope before the last step was 
calculated to acquire the real loading rate. After collecting both of the last rupture forces 
and loading rates, and categorizing the loading rates into four levels, we can generate 
histograms of the measured dissociation force distribution at different loading rate levels – 
lowest (100 ± 40 pN/s), lower median (700 ± 300 pN/s), higher median (6000 ± 2000 pN/s 
and highest (45000 ± 15000 pN/s) , and different potential levels – -100mV, 0mV, and 




loading rate level under different potential conditions could be seen in the supplementary 
information).  As loading rates increased, the range of the dissociation forces were 
expanded and the peaks in the histograms, which identify the most frequent force 
magnitudes, shifted towards higher magnitudes for different potential conditions. It should 
be noticed that the counts of rupture force shown in histogram for positive potential force 
measurement were much lower than that of open circuit, zero and negative potential 
situations, which is just resulted from the significant decrease of unbinding events, as 
exhibited in Table 1.  
 
Figure 3.3 Rupture force distribution of thrombin-aptamer complex for different 





For the thrombin-aptamer complex, the distribution of rupture forces shows 
periodic peaks in the histogram, which may indicate the existence of an elementary binding 
force corresponding to dissociation of a single protein-aptamer complex. Auto correlation 
function (ACF) was applied on force distributions for estimating the magnitude of the 
elementary binding force as a function of the loading rates under different controlled 
potentials 66, as shown in Fig. 5 (The detailed ACF plot for each loading rate level under 
different potential conditions is provided in the supplementary information). Periodically 
spaced peaks in auto correlation function plots confirm the existence of the elementary 
binding force i.e. the force quantum for each potential condition. The period of the 
Figure 3.4 Rupture force distribution of the thrombin-aptamer complex for 




repeating peaks in the autocorrelation plots was measured to estimate the force quantum, 
and the computed force quanta as a function of loading rates for all potential conditions are 
shown in Table 2.   
  
  
Figure 3.5 Autocorrelation function of rupture force distribution 
















Open circuit 20 26 33 40 
(-)100mV 21 27 34 40 
0mV 21 26 33 39 
(+)100mV 16 22 27 33 
 
For the positive electric field, it is observed that the measured unbinding force 
between the thrombin and aptamer is lower, while under zero and negative electric fields 
did not show noteworthy influence on the binding strength of the complex compared to 
open circuit situation. These phenomena could be caused by the electrostatic pulling down 
force generated by positive electric field on the negatively charged DNA aptamer 67, which 
weaken the binding between the complex and thus attenuate the force interaction. While 
under negative electric fields, the pushing up force exerted by negative potential on the 
negatively charged DNA aptamer does not influence the conformation states of the aptamer 
significantly, thus the binding and force interaction between the complex are not changed. 
Based on those force quanta and loading rates, the dynamic force spectrum under for 




The dissociation process of thrombin-aptamer complex with applied load may be 
modeled via a single energy barrier model as proposed by Evans and co-workers 68-73. 
When a bound complex is not subjected to external loads, the energy barrier to be overcome 
during the dissociation process is very high, and thus results in a low probability for the 
complex to dissociate.  When the bound complex is pulled apart under applied loads, the 
work done by loads could decrease the height of the energy barrier, and consequently 
increases the probability of dissociation. The probability of dissociation p can be expressed 






































                 (4) 
In the equation (4), Fβ is the thermal force that dominates the spread of the 
distribution; rf is the loading rate; toff is the spontaneous dissociation time; and xβ is the 
width of the transition state barrier.  According to equation (4), a peak in the probability 
distribution appears as the exponential increase in failure rate due to applied force crosses 
over to the precipitous decline in bond survival with increasing force 69. The rupture force 




Fpeak, corresponding to the peak of the probability density distribution as a function of 
loading rate is then determined to be: 
                                                                                                    
(5) 
According to equation (5), the Fpeak, i.e. the force quantum has a linear dependence 
on logarithm of loading rate, which has a good agreement with the trend shown in Fig.6. 
Thus single energy barrier model described in equations (4) and (5) may be used to describe 
the thrombin-aptamer interaction.  The slope and x-intercept of the fitted data for each 
potential condition were used to two important kinetic parameters, the width of transition 
















Table 2.3 Kinetic parameter estimation for each potential condition 
 xβ (nm) toff (ms) 
Open circuit 0.81 720 
-100mV 0.82 690 
0mV 0.83 740 
100mV 0.85 120 
 
From Fig.6, since the slopes of data trend for each electric potential condition are 
all similar, thus the values of transition state barrier xβ are comparable. Meanwhile, the data 
trend of positive potential condition has a significantly larger x-intercept then the other 
three conditions, which results in a much lower spontaneous dissociation time toff, and this 
could be the kinetic explanation of the binding weakening effect due to the application of 





2.4.2 Analytical Modeling 
The solution for equation (3) provides the distribution of electrostatic potential and 
the electric field in the DNA aptamer-thrombin layer (layer is pictorially represented in fig. 
1 (B)). We consider the case when a single thrombin molecule is placed inside the thrombin 
containing domain defined by the length P in fig. 1 (B). The thrombin molecule is assumed 
to be linear for this purpose and we uniformly distribute the positive charge carried by it 
over its length of 2.0 nm 1, which is the diameter of its globular protein form. The 
electrostatic force experienced by this single protein is due to the electric field inside 
domain P, calculated from the solution of equation (3). The force is calculated for the 
electrode potentials of (-) 300 mV, (-) 200 mV, (-) 100 mV, 0 mV, (+) 100 mV, (+) 200 
mV and (+) 300 mV and different heights of the linker sequence. The calculated forces as 
a function of applied potentials are plotted for different linker heights in fig. 7(a) and (b), 
for the two DNA surface grafting densities 𝜎 = 1011 cm-2 and 𝜎 = 1012 cm-2, respectively.  
 
Figure 7.7 Force on a single thrombin inside the layer of thrombin on top of DNA 
aptamer at grafting density of (A) 𝜎 = 1011 cm-2 and (B) 𝜎 = 1012 cm-2 for different 35-




It is observed from fig. 7 (A) and (B), that the force on thrombin is increasingly 
positive or repulsive in nature, away from the electrode surface, for the positive potentials. 
The force is also increasingly positive in sign as the linker undergoes 
condensation/shortening as depicted by decreasing fractions of linker length H1. The effect 
is more pronounced at lower grafting density of 𝜎 = 1011 cm-2. This suggests that with 
increasing condensation of the DNA and lesser grafting density, the shielding effect of the 
negatively charged backbone is easier to overcome. Rant et al. have previously shown the 
condensation of DNA on positively charged metal surface 67. The theoretical model 
described here does not incorporate the conformational changes in the DNA strands which 
is a dynamic process, but we can reduce the linker height to model the condensation of the 
DNA, thus looking at snapshots of the entire condensation process. We find that for any 
particular electrode potential and grafting density, the force on the thrombin becomes 
increasingly positive as the DNA condenses onto the surface due to positive electrode 
potential. In fact, at certain scenario (e.g. at linker condensations of 0.75, 0.5 and 0.25 of 
the original length H1, for (+) 200 mV at 𝜎 = 1011 cm-2 ) it gives rise to entirely positive 
force on the thrombin. At physiological pH, thrombin is a positively charged molecule. For 
such a case, the positively charged thrombin is placed in a domain where the electric field 
is positive. This can result in spontaneous dissociation of thrombin from the complex, as 
the nature of the force in this case is repulsive. This has been observed and reported by our 
group in previously published work 1, 2. At negative electrode potentials, the negatively 
charged backbone of the DNA experiences a repulsive force and so condensation of linker 
will not take place. However, we can explore the case of a short linker by again considering 




attractive, and it is predicted to stay in its binding mode with the DNA aptamer, which is 
also reported in our previous work 1,2. It may be noted that, with greater linker heights, and 
thus longer effective DNA lengths, the increase in negative charges produces more 
attraction to the positively charged thrombin. Fig. 7 also shows that the repulsive force is 
lesser at higher DNA grafting densities, wherein the negative charges screen the effect of 
positive field. 
To isolate the effect of the electric field on the binding force of the complex of 
thrombin and DNA aptamer the difference in the measured binding force on thrombin 
between the 0 mV and the (+) 100 mV cases is compared for experimental and theoretical 
predictions. The results from the model as well as the experiments are presented together 
in Table 2.4.  
Table 2.4 Comparison between the difference in force between electrode potentials 
of (+) 100 mV and 0 mV, on a single thrombin placed inside the thrombin layer, 
derived from the theoretical model and the experiments 
Difference in 
force between 
(+) 100 mV 
and 0 mV 
Model with 𝜎 
= 1011 cm-2 
Model with 𝜎 
= 1012 cm-2 
Experiments 
Force (pN) 2.15 ± 0.29 3.97 ± 0.87 5.26 ± 0.77 
*The error is the standard deviation from the mean for (a) the different cases of 35-mer 
linker condensation in the theoretical model and (b) the different loading rates for the 
experiment  
It is observed that the force difference values are of the same order of magnitude 
and sign. In our previous studies 1, 2, we have shown that the dissociation of the thrombin-
aptamer complex is possible by the application of electric field, however the reason behind 




4 indicate that the repulsive forces due to the polarity of thrombin molecules in positive 
electrical field is primary contribution to the reduction of binding forces measured in the 
experiments.  
2.5 Conclusion 
In summary we find that the influence of electrostatic fields on unbinding 
interaction between thrombin and its aptamer has been quantitatively characterized. 
Experiments were conducted to obtain statistically significant responses and dissociation 
forces associated with the last binding event were analyzed to understand the effect of 
electric fields on molecular binding. The results from experiments show that the specific 
binding events of the pair are drastically reduced under the positive electric fields. It is 
revealed that moderate electric fields can be utilized to weaken or disrupt the binding 
between thrombin and aptamer complex. Particularly we show that positive electric 
potential of (+)100 mV can decrease the force interaction between the thrombin and 
aptamer and disrupt the binding. Whereas, zero and negative i.e. (-)100 mV, electric 
potentials can maintain the force interaction and number of binding between the thrombin 
and aptamer. The single energy barrier model was utilized to estimate kinetic parameters 
that determine dissociation process of thrombin-aptamer complex.  These results suggest 
that the significant drop of spontaneous dissociation time is the result of the repulsive 
forces applied on the thrombin protein, under positive surface potentials. From the 
continuum electrostatic model, we find that the force difference between neutral and (+)100 
mV electric potential cases is similar in magnitude to that obtained from the experiment. 
We conclude that the modulation of the binding between the thrombin and aptamer 
complex can be extended to other systems utilized in electrically actuated biosensors and 
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CHAPTER 3.  LABEL FREE THROMBIN DETECTION IN PRESENCE 
OF HIGH CONCENTRATION OF ALBUMIN USING AN APTAMER-
FUNCTIONALIZED NANOPOROUS MEMBRANE 
(Modified from a paper published in Biosensors and Bioelectronics) 
Agnivo Gosaia, Brendan Shin Hau Yeaha, Marit Nilsen-Hamiltonb and Pranav Shrotriyaa,2 
a Department of Mechanical Engineering and b Department of Biochemistry, Biophysics and 
Molecular Biology, Iowa State University, Ames, IA 50011, USA 
3.1 Abstract 
Nanoporous alumina membranes have become a ubiquitous biosensing platform for a 
variety of applications and aptamers are being increasingly utilized as recognition elements in 
protein sensing devices. Combining the advantages of the two, we report label-free sensitive 
detection of human α-thrombin by an aptamer-functionalized nanoporous alumina membrane 
using a four-electrode electrochemical cell. The sensor response to α-thrombin was determined in 
the presence of a high concentration (500 M) of human serum albumin (HSA) as an interfering 
protein in the background. The sensor sensitivity was also characterized against γ-thrombin, which 
is a modified α-thrombin lacking the aptamer binding epitope. The detection limit, within an 
appreciable signal/noise ratio, was 10 pM of α-thrombin in presence of 500 M HSA. The 
proposed scheme involves the use of minimum reagents/sample preparation steps, has appreciable 
response in presence of high concentrations of interfering molecules and is readily amenable to 
miniaturization by association with existing-chip based electrical systems for application in point-
of-care diagnostic devices. 
                                                 
2 Corresponding author 
Address: 2019 Black Engineering Building, Ames, IA 50011 
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3.2 Introduction 
Nanoporous anodized alumina or aluminum oxide (NAAO) membranes are increasingly 
assuming an important role in chemical/biological sensing due to several desirable properties like 
non-conductivity, structured nanopores, high pore density as well as surface to volume ratio, and 
ease of functionalization.1 NAAO membranes thus have exciting potential in biosensing devices 
through miniaturization and integration into lab-on-chip and point-of-care diagnostic systems. 
NAAO membranes have found application as biosensor platforms in several niche  biosensing 
areas including nucleic acid sensing2, 3, detection of bacteria4, 5, virus particles6, antibody7 and 
protein sensing.8 
The hallmark of a good biosensor is a reliable receptor or recognition element apart from 
the robust sensing platform. In this regard, nucleic acid aptamers are prime candidates for 
recognition elements towards target analyte (e.g. proteins) in many biosensing devices.9 Aptamers 
are short chain oligonucleotides that are being increasingly investigated for biosensing due to their 
high affinities, specificities, small sizes, robustness for handling/storage in terms of adaptability to 
a wide range of temperatures. They can potentially replace antibodies for analytical and therapeutic 
applications.10, 11 Aptamer based sensors have been previously used in both labeled or label-free 
devices.12 
Label-free biosensing techniques involve detection of target-probe binding, which can 
provide information on binding kinetics, association/dissociation rates and constants and 
determine binding/unbinding events. In particular, label-free electrochemical impedance 
spectroscopy (EIS) based characterization techniques12 offer great flexibility in the incorporation 
of NAAO membranes into existing detection schemes and could facilitate the realization of 




sensor devised for real-world application where the target concentration can be much lower than 
the concentrations of non-target biomolecules. This demands thorough consideration in improving 
the efficacy of such sensors.  
In this study, we have determined the sensitive label-free detection of human α-thrombin 
with an aptamer modified NAAO in a custom-made four-electrode electrochemical cell (Fig. 1C) 
using the EIS technique. Previously Escosura-Muniz et al.,8 achieved a low concentration sensing 
of α-thrombin in whole blood using gold nanoparticle-based aptamer sandwich systems in NAAO 
membrane pores. In their work, the NAAO membrane is the working electrode in the 
electrochemical system, in which the biomolecular complex attached to the surface of the NAAO 
membrane may be influenced due to the direct effect of the electric field created by the electrode. 
In fact, the actuation/modulation of nucleic acid and their ligands due to electric field has been 
previously reported to be capable of affecting the sensor response. To avoid this effect, we have 
devised an indirect method to measure the impedance changes on the membrane by using a four-
electrode set-up. Recently, Zhao et al.13 have reported the label-free detection of α-thrombin by an 
aptamer-modified NAAO membrane using a two-electrode method, but they did not test the 
detection efficacy in presence of interfering proteins in the sample. Also, in the four-electrode 
method the voltage-measuring electrodes are not under the effect of the current-carrying outer 
electrodes and thus have better measurement accuracy than with the two-electrode system.  
Under physiological conditions in human blood, the α-thrombin concentration can range 
from a few nanomolar (nM) (unperturbed blood) to a few hundred nM (when the clotting cascade 
is activated).14 The sensitivity of the proposed sensor has been rigorously investigated for 
physiologically relevant α-thrombin concentrations in presence of a high background of 500 




µM15). HSA is the most abundant protein in human serum, makes up close to 60% of blood plasma 
proteins and is a major contributor to non-specific interactions for biosensors. We also utilized γ-
thrombin as a negative control, which is analogous in structure to α-thrombin but lacks the residues 
for selective binding to the aptamer.  
By testing our aptamer-based sensor in presence of high concentration HSA we can 
effectively establish the specifity and selectivity of the proposed sensing scheme. The novelty of 
our design scheme lies in label-free detection using minimal sample preparation steps and the ease 
of miniaturization for integration with point-of-care diagnostic devices focusing on improved 
specificty and selectivity. 
3.3. Experimental methods 
3.3.1 Materials 
The NAAO (Sigma Aldrich, Whatman), having nominal pore diameters of 20 nm and 
membrane thickness of 50 µm, were used for the experiments. This membrane was chosen based 
on earlier reports and with respect to the sizes of the biomolecules involved.16-18 Thiolated 
thrombin-binding aptamer (TBA) was obtained from Integrated DNA Technologies (IDT) with 
the sequence 5'-/5ThioMC6-D/GCCTTAACTGTAGTACTGGTGAAATTGCTGCCATTGGTT 
GGTGTGGTTGG-3'. The bold letters denote the aptamer sequence that binds selectively to 
human α-thrombin.19, 20 Human α-thrombin, γ-thrombin, serum albumin (HSA), lysozyme, and 6-
mercapto-1-hexanol (MCH) were procured from Thermo-Fisher Scientific. The electrolyte used 
for sensing experiments was 1 mM Fe(CN)6
4-/Fe(CN)6
3-redox couple in PBS (137 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 5 mM MgCl2, pH 7.4 at room temperature). All the 
chemicals used for electrolyte were purchased from Sigma-Aldrich. All solutions were prepared 





3.2.2 Preparing membranes for experimentation 
 
The NAAO membranes were cleaned/sonicated with isopropanol, ethanol and ddH2O. 
Afterwards, one side of the membranes was sputter-coated with 60 nm of gold, followed by 
washing with isopropanol, ethanol and ddH2O. The TBA was brought to 1 µM TBA in PS buffer 
(PBS without MgCl2) and stored refrigerated. Before an experiment an aliquot was heated to 90°C, 
MgCl2 was added and the solution was allowed to slowly cool down to room temperature before 
being put on the gold coated NAAO membrane, which was then left at 4°C for 12 h to immobilize 
the TBA. The NAAO membrane was washed with PBS and further incubated for 1 h at room 
temperature with 3 mM MCH in ddH2O to passivate the surface followed by washing with PBS. 
These steps are represented graphically in Fig. 1A. 
 
Figure 3.1 : (A) Schematic showing membrane immobilization steps (B) The four-electrode 
scheme is shown (C) the Teflon cell as used in the electrochemical experiments with the NAAO 




3.3.3 Electrochemical sensing 
For all electrochemical experiments a custom-made Teflon cell (Fig. 1C) was used. The 
four-electrode method was utilized to measure the impedance changes for the NAAO membrane 
(represented in Fig. 1B). Platinum wires were used for the working (WE) and counter electrodes 
(CE) whereas Ag/AgCl wires (Invivometric) were used as the two reference electrodes (RE). EIS 
was carried out with an AC perturbation signal of 5 mV over a DC potential equal to the open 
circuit potential of the system, within the frequency range of 10 kHz-0.1 Hz. Equal volumes of 
protein solution (α-thrombin as analyte and other proteins for negative controls) prepared in PBS 
were injected onto the port of the Teflon cell containing the TBA functionalized side of the 
membrane (Fig. 1B). The concentration of each injection was determined to achieve the desired 
target concentration inside the electrochemical cell to obtain a calibration curve for the titration 
experiment. EIS was carried out after 30 minutes to provide ample time for diffusion of protein 
based on the reported association constant of α-thrombin and its aptamer.21 The system was tested 
separately for selectivity for α-thrombin compared with γ-thrombin and HSA as negative controls. 
It was also tested for specificity for α-thrombin  over γ-thrombin and lysozyme in the presence of 





3.4 Experimental results and discussion 
3.4.1 Characterization of impedance change 
Figure 3.2 (A) A representative frequency response (Bode plot) and (B) a 
representative Nyquist plot, at 10 nM concentration of different proteins.  The 
black curve on the Nyquist plot is the modified Randle’s circuit fit for α-thrombin; 
(C) the membrane im the membrane impedance Zmem and (D) ΔZmem is plotted of 
the aptamer functionalized membrane for different protein concentrations. Each 
titration experiment was repeated at least 3 times. The error bars correspond to 





Figs. 2A and 2B show the frequency responses i.e. the Bode plot and the Nyquist plots of 
the system, respectively, where the responses to different proteins at 10 nM were determined for 
separate experiments. The data in Fig. 2A contains a significant contribution from the solution 
resistance, which is influenced by the different charges on the proteins. This solution impedance 
dominates more at the higher frequencies of the AC perturbation voltage used in EIS. The system 
impedance Zsystem does not explicitly capture the effect of aptamer-protein impedance occurring on 
the membrane surface. To better understand the changes occurring on the membrane it is useful to 
analyze the Nyquist plots in Fig. 2B in which the solution impedance is subtracted from the real 
axis of the Nyquist plot. From Fig. 2B it is observed that the shape of the Nyquist plot for α-
thrombin (analyte) was appreciably different from the shape with no protein, whereas those for γ-
thrombin and HSA (negative controls) were more closely aligned with the latter plot. The EIS data, 
in the form of Bode plots (Fig. 2A) and Nyquist plots (Fig. 2B), were fit to the modified Randle’s 
circuit (explained in supplementary information S1) and the relevant membrane parameters, 
namely pore resistance Rp and membrane capacitance Cmem were extracted.  
Supplementary Figs. S2A and S2B show the Rp and Cmem for the α-thrombin, γ-thrombin 
and HSA titrations. It is observed that, at lower protein concentrations, the data for Rp and 
particularly that for Cmem had less resolution. As the titration progressed, Rp decreased appreciably 
with the selective and specific binding of α-thrombin to TBA. Due to more charges accumulating 
on the membrane resulting from the α-thrombin-TBA complex, Cmem increased progressively. The 




response for the negative controls did not scale to the same extent. The membrane impedance Zmem 
(depicted in Fig. 2C) was calculated for a frequency f = 100 Hz (chosen from Fig. 2A as an 
inflection point of the frequency response curve) and this data, as plotted in Fig. 2C shows better 
resolution compared to the separate Rp and Cmem data.  
Zmem was calculated as below: 







To further resolve the response, the difference in impedance (Zmem)final-(Zmem)zero concentration 
= ΔZmem was calculated for each of the concentrations of protein and plotted against protein 
concentration (Fig. 2D). This plot improved the distinction of the response at lower α-thrombin 
concentrations (i.e. 0.1 nM and 0.5 nM) compared with the negative controls. 
  




3.4.2 Sensitivity in presence of a high concentration of interfering protein 
 
Figure 3.5 ΔZmem is plotted for the protein titration in presence of 500 µM HSA as a 
background in the electrolyte. Impedance is calculated at f = 100 Hz. The response for the α-
thrombin titration is fitted to a Langmuir isotherm to calculate dissociation constant KD. 
Each titration experiment was repeated at least 3 times. The error bars correspond to 
standard error of the mean. 
 
The system was further tested in presence of a high concentration of HSA (500 µM), the 
most abundant blood protein, as an interfering protein. In absence of whole blood, this is deemed 
as a rigorous test for the sensor with a focus to real world applications. With HSA present as an 
interfering protein, human lysozyme (also positively charged like α-thrombin) was chosen as 
another negative control. Thus we have tested for both structural and charge similarities by using 
γ-thrombin and lysozyme respectively. From Fig. 3 we observe that the sensor functions 
considerably well for both the higher and lower concentration zones. In fact, an appreciable 




3.4.3 Sensor parameters 
The response of the sensor ΔZmem is proportional to the number of aptamer-protein 
complexes formed at each concentration of α-thrombin. The response or calibration curve for α-
thrombin  in Fig. 3 is fitted to the following 1:1 Langmuir isotherm equation: 
                               𝛥𝑍 ∝  𝛩 =   
[𝛼−𝑡ℎ𝑟𝑜𝑚𝑏𝑖𝑛]
[𝛼−𝑡ℎ𝑟𝑜𝑚𝑏𝑖𝑛]+𝐾𝐷
  (1) 
where, Θ = fraction of bound TBA and KD = dissociation constant for the aptamer-protein 
complex. The KD for the TBA/α-thrombin complex in the presence of 500 µM HSA was calculated 
as 0.18 nM by the Langmuir isotherm fit according to eqn. (1) (shown in Fig. 3 along with 
confidence interval of 95%). The reported solution KD for this complex is ~ 3 nM.
22 The calculated 
KD in the present study is probably lower due to molecular crowding
23 of the aptamer immobilized 
on the membrane surface. For characterization of the sensor, we denote the absolute value of ΔZmem 
as the signal S, whereas the response due to blank injections (devoid of any protein) is considered 
as noise N. The signal to noise ratio is thus defined as S/N = Smean/σnoise, where, Smean is the mean 
signal and σnoise is the standard deviation of the noise N, following the discussions established in 







Table 3.1 Sensor parameters 
HSA 
Background 












30 7.89 7.85 
500  5.08 5.11 




30 1.37 1.41 
500  0.98 1.00 




30 7.8 7.76 
500  1.01 3.98 




30 3.46 9.24 
500  1.01 2.67 
 
According to Currie et al.26 and other reports24, 25 on electrochemical sensors, an 
appreciable S/N ratio is 3, which was satisfied by the α-thrombin titration but not satisfied by the 
γ-thrombin titration, both in the presence of 500 µM HSA. These results are consistent with the 
selectivity of the sensor towards α-thrombin over other proteins. Also, the S/N ratios for 0.1 nM 
and 500 nM α-thrombin were higher in the presence of 500 µM HSA compared 0 and 5 µM HSA. 
It may be noted that the concentration of α-thrombin in a sample could be determined by 
comparing the results from different dilutions of an α-thrombin solution of unknown concentration 





Table 3.2 Comparison of present work with other publications 
Sl. 
No. 
Reference Method Platform Detection limit 
1 Allsop T. et al. 27, 
2017 
Optical / Surface Plasmon Aptamer modified 
metal/semiconductor 
optic fiber; label free 
100 pM in 4.5 % w/v 
Bovine Serum Albumin 
2 Lin K. et al. 28, 
2017 
Electrochemical 
(impedance) / 3-electrode 
Aptamer-functionalized 
MoS2 nanosheet 
53 pM in 1% human 
serum 
3 Zhao X. et al. 13, 
2017 
Electrochemical 
(impedance) / 2-electrode 
/ NAAO membrane 
Aminated aptamers 
grafted on inner wall; 
label free 
1 pM in PBS 




electrode / gold 
microelectrode array 
Bivalent aptamer 
system; label free 
5.5 nM in 10 mM MES 
buffer, pH 6.0 
4 Jiang Z. et al. 30, 
2014 
Optical / UV-Vis Aptamer -antibody 
sandwich ; ELISA type 
sensor 
80 pM in PBS 
5 Escosura-Muniz 
A. et al. 8, 2013 
Electrochemical 
(voltammetry) / 3-
electrode / NAAO 
membrane 
Aptamer-antibody 
sandwich assay with 
AuNP tags + silver 
 
5 pM in whole blood 
(membrane rinsed with 
PBS after incubation 
with blood) 
6 Xiao Y. et al.31, 
2005 
Electrochemical / 3-
electrode / gold disk 
electrode 
Aptamer based using 
methylene-blue label 
64 nM in diluted 50 % 
calf serum 
7 This work Electrochemical 
(impedance) / 4-electrode 
/ NAAO membrane 
Thiolated aptamers; 
label free 
10 pM in presence of 
500 µM HSA in PBS 
 
Table 3.2 shows how the proposed sensor compares with some other reported 
approaches/designs. It may be observed that NAAO membrane based impedimetric aptasensors 
are particularly sensitive to low concentrations of target analyte. The results reported in this study 
also demonstrate that our approach can be a viable alternative for label-free portable biosensors 





3.4.4 Reusability of the membrane 
To evaluate reusability, a freshly made NAAO was used to measure α-thrombin, then was 
washed in PS buffer and stored at 4 °C in dry state for 7 days. Afterwards it was heated in PS 
buffer for 5 min at 58°C (which is higher than the melting temperature for TBA) to denature the 
aptamer and dissociate remaining aptamer-protein complexes. The NAAO was again washed in 
PS buffer and used in α-thrombin titration experiment in the absence of HSA. From Fig. 5, it is 
observed that, the NAAO responded equally as well after 7 days in detecting α-thrombin. 
In fact, the reused membrane could achieve remarkably similar sensitivity and dynamic 
range as compared to the freshly used membrane. However, the detection in presence of high 
background is not reported in this study. We are at present, investigating it and extending the study 
to other protein-aptamer systems. 
Figure 3.6 The α-thrombin titration for a re-used membrane is compared with that of a 
fresh membrane. All measurements were conducted at least 3 times. The error bars 




3.4.5 Discussion of membrane impedance change 
Figure 3.7 shows the comparison for Zmem during α-thrombin titrations for varying 
concentrations of HSA (0, 5, and 500 µM) in the electrolyte. It is observed that, in the presence of 
0 and 5 µM HSA, the impedance value reached a minimum as the α-thrombin concentration 
increased and then increased as the concentration was raised beyond 10 nM. This response of the 
system resulted in the loss of sensing performance. Particularly, at 0 µM HSA, for very high α-
thrombin concentration (e.g. 300 and 500 nM), the impedance is equal/greater than that at the start 
Figure 3.7 The membrane impedance Z is plotted for an α-thrombin titration in the 
presence of 0, 5, and 500 µM HSA. The mean value for each case of background is 
shown. Impedance is calculated at f = 100 Hz. (C) The resistance Rp  and (D) capacitance 





of the titration. This is because Cmem decreased (as it scales inversely with double layer thickness) 
and Rp increased compared to the value at zero concentration (Figs. 4B and 4C). However, this 
problem was mostly mitigated with a high concentration (500 µM) of HSA present in the system 
from the start of titration. The baseline, corresponding to the zero-concentration of titrated α-
thrombin, was shifted to a higher value in the presence of 500 µM HSA (Fig. 4A). The average 
baseline impedances at the start of the experiments were ~16 Ohm for 500 µM HSA and ~12-11 
Ohm for 0 and 5 µM HSA. It is hypothesized that, in the presence of high HSA (500 µM), non-
specific adsorption is maximized at the start of the experiment, which increases the baseline. 
Hence, the sensor can achieve a greater dynamic range and resolution even in the presence of high 
HSA.  
NAAO membrane impedance depends on several factors including surface charge density 
due to the nucleic acids and attached or adsorbed proteins, which is influenced by electrostatic and 
non-electrostatic interactions.18, 32, 33 At low bulk salt concentrations, Cbulk , compared to the 
surface charge concentration ΔC on inner nanopore walls and/or on outer surface,18, 33 pore 
conductance is enhanced (which reduces the impedance) due to a local increase in the counterion 
concentration required to balance the charges on the grafted biomolecules. The membrane 
impedance Zmem for pore radius a, porosity α, ion diffusion coefficient D, membrane channel 
length L, and cross-sectional area A can be expressed by the following expression.33, 34 







where e = electron charge, kB = Boltzmann constant, T = system temperature. For this 
study,  𝛥𝐶 =  
𝑁𝑆
𝑎
 ~ 10 4M ≫ 𝐶𝑏𝑢𝑙𝑘 = 0.1 M where Ns = the surface grafting density of nucleic 




1 e- negative charge, and we hypothesize that ΔC  increases to a greater extent in response to α-
thrombin due to its high affinity for TBA in comparison to the low affinity non-specific 
interactions with other proteins that bind to a lesser degree. Thus, the pore impedance decreases 
much more with increasing α-thrombin concentrations compared with proteins with low or no 
affinity for the aptamer.   
In a previous study, Rotem et al.37 observed an increase in current through a TBA-modified 
single nanopore on binding with α-thrombin, suggesting a concomitant decrease in the pore 
impedance, which supports our observation. They argued that ion flow through the nanopores 
could be affected due to the biomolecular surface charge as well as by the configurational change 
of aptamer at the pore entrance due to binding with α-thrombin. However, with increasing numbers 
of α-thrombin-TBA complexes, giving rise to greater steric hindrance to ion flow across the 
nanochannels of the membrane, the mechanism of “volume exclusion”38 will dominate over the 
“surface-charge” mechanism.33 The result will be a decrease in conductance and thus an increase 
in membrane impedance. In the event of membrane impedance being dictated by volume exclusion 
the pore resistance Rp increases and can be expressed as below,17, 39  
                                                                𝑅𝑝 =  
𝐿
𝜋𝛬𝑎2
        
where Λ is the specific conductivity of the electrolyte in the nanochannel. If we consider 
that Λ is unchanged, then the abundance of protein-aptamer complexes can reduce the effective 
pore radius and thus increase Rp. This could explain the increase in Rp , which in turn increases 
Zmem, at very high concentrations of α-thrombin. We observed more of this effect (Figs. 4B and 
4C) in the presence of 0 and 5 µM HSA at 300 and 500 nM α-thrombin. Karnik et al.40, 41 also 
showed that, with increasing complex formation, the conductance decreases after a certain point 




The previous discussion considers surface charge effects on nanochannels but in the real 
scenario the nucleic acid-protein complex is, in effect, a polyelectrolyte layer and thus the sizes 
and shapes of the biomolecules must be considered to provide a thorough explanation for the 
conductance change. Tagliazuchhi et al. 42 reported that polyelectrolytes on the outer surface of 
the nanopores, compared to those on inner walls, can lead to equal or better rectification of ionic 
current, depending on biomolecules charge and ionic concentration. The NAAO  membrane used 
in this study were sputter coated with a ~ 60 nm thick film of gold. Due to the physical deposition 
process most of the gold was accumulated on the mouth of the nanopores, with much less 
penetration into the nanochannels. Thus, the thiolated aptamers were likely aggregated around and 
closer to the mouth of the pore.  
Interestingly, Zhao et al.13 immobilized aptamers throughout the inner surface of the 
nanopores and demonstrated an increase in impedance with formation of α-thrombin-aptamer 
complexes inside the NAAO membrane, for their scheme of sensor arrangement. However, they 
did not report the detection of the analyte/target in presence of high concentrations of other proteins 
of low affinity for the aptamer such as HSA, which we have demonstrated in the present study. 
The nature of the impedance change described in the present study is opposite of that discussed in 
the work by Zhao et al. Though previous literature,34, 37, 39-42 as described above, support our 
observations, it is to be noted that they only consider the instance of receptor-target interaction and 
thus it is still not clear how the presence of high concentrations of HSA improves the sensitivity 
in our study. This effect of HSA demands greater inspection of the interaction of proteins with 
aptamers grafted to nanoporous membranes and to other exposed portions of the membranes, such 
as the hexanol-modified gold surface. Computational modeling considering buffer composition, 





In this study we have established a sensitive and selective aptamer-functionalized NAAO  
membrane sensor for α-thrombin detection, which has the potential to be integrated into portable 
systems due to the feasibility of implementing the EIS scheme in hand held sensors. We have 
shown that the sensor is responsive to α-thrombin in the presence of an excess of HSA. We also 
found that prior exposure of the system to HSA improved the baseline, possibly through the 
saturation of the available sites for non-specific adsorption. However, there is room for further 
improvement in sensor signal through the engineering of several factors like reduction of the 
membrane cross sectional area exposed to the electrolyte, closer placement of the reference 
electrodes with respect to the membrane and adjusting the bulk salt concentration in the electrolyte 
to control the surface charge effect. This scheme of detection will be extended to other protein-
ligand systems to further establish its efficacy. 
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CHAPTER 4.  COMPETION SENSING MODE FOR ELECTROCHEMICAL 
DETECTION OF PROTEINS  
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4.1 Abstract 
Conventional label-free sensing approaches rely on discriminating the absorption or 
binding of the target analyte to a sensitized surface.  To ensure that the sensor response is specific 
to the target analyte, the sensor surface is coated with receptor molecules with binding affinity 
towards the target analyte.  In complex matrices such as biological fluids, the sensor response is 
proportional to both the specific binding of analyte molecules to the receptors (desired signal) as 
well as non-specific binding of interfering molecules (noise) on the surface.  We propose a novel 
sensing approach that can overcome the limitations in specificity due to a lack of sensitive 
discrimination between specific binding of target analyte and non-specific binding of interfering 
molecules. We will utilize the strategy for specific and sensitive detection of ebolavirus biomarkers 
in biological fluids. The proposed sensing strategy involves functionalizing sensing surfaces with 
receptor molecules with a weak reversible bond such that receptor molecules can be released from 
the surfaces on exposure to the analyte. 
Keywords : aptamer, competition mode, microcantilever, electrochemical  
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Conventional label-free sensing approaches rely on discriminating the absorption or 
binding of the target analyte to a sensitized surface.  To ensure that the sensor response is specific 
to the target analyte, the sensor surface is coated with receptor molecules with binding affinity 
towards the target analyte.  The sensor response is proportional to the number of analyte molecules 
bound to the sensitized surface.  Consequently, the smallest detectable level and the detection 
sensitivity for the analyte are limited by two parameters: 1) the binding affinity between the analyte 
and receptor molecules; and 2) the sensor sensitivity for analyte/receptor complexes.  There has 
been considerable work on improving the sensitivity of label-free sensors for detecting extremely 
low levels of analyte/receptor complexes, but the low binding affinity of receptors frequently limits 
the detection and identification of target analyte.  Detection is further exacerbated when the target 
analyte concentration is much smaller than other interfering molecules that may bind the receptor 
and create almost the same magnitude noise (from non-specific binding of interfering molecules) 
as the desired signal (from specific binding of analyte/receptor).  
We propose a novel sensing approach for chemical detection in solution that can overcome 
the limitations in: sensitivity due to low binding affinity between receptor/analyte combinations 
and specificity due to non-specific binding of interfering molecules. The proposed sensing strategy 
involves functionalizing an array of sensing surfaces with receptor molecules with a weak 
reversible bond such that receptor molecules can be released from the surfaces on exposure to a 
liquid medium. This strategy is based on the hypotheses that the release rate of receptors from such 
surfaces strongly depends on the analyte concentration and resolving the release rate can increase 
sensitivity by an order of magnitude and lower the analyte detection threshold compared with 




We have formulated our hypotheses based on our preliminary experimental results that 
show that if such a receptor coated surface is introduced into a solution with no analytes, the release 
rate of receptor is limited by the equilibrium between receptor and the surface and the rate of 
diffusion of the molecules away from the sensor surface.  In contrast, when the surface is 
introduced into a solution with analyte, the receptors release at an accelerated rate, being consumed 
by diffusion and reaction with the analyte in the solution. Consequently, the rate of release 
becomes strongly dependent on the analyte concentration leading to approximately 20 times 
increase in sensitivity and 15 times lower detection thresholds for sensing of analytes in aqueous 
solutions compared to conventional sensing approach. (in microcantilever based biosensor).  
4.3 Methodology 
4.3.1 Label free biosensors 
Label-free sensors are being studied for chemical detection because of their potential for 
being easily deployable, miniaturized, portable and inexpensive sensor systems.1-48 Devices based 
on a range of sensing elements including nanotubes32, 33, 48, nanowires34, 49, microcantilevers50, 
surface plasmon resonators36, electrochemical electrodes39, quartz microbalances42 and fiber optic 
cables35 have been tested for label-free sensing. All the above sensing approaches rely on 
discriminating the binding of analyte molecules on a receptor-coated surface. When the receptor 
coated surface is exposed to analyte molecules in solution, the Langmuir equation may be used to 
estimate the fraction of receptor molecules binding the analyte as follows: 









where 𝐾𝑎is the binding affinity between receptor and analyte molecules and [𝐵] is the 
concentration of analyte molecules. At low concentrations of analyte, the surface coverage 
becomes proportional to [𝐵] as shown above. The sensor detection threshold and sensitivity depend 
on two parameters: 1) the binding affinity between analyte and receptor; and 2) the smallest 
fraction of analyte/receptor that can be resolved on the sensor surface. The current state-of-art 
sensors can demonstrate extremely high sensitivity for resolving extremely small levels of 
analyte/receptor binding in controlled conditions leading to detection of single molecule binding 
to the surface.51 However, the low affinities of many receptors for analyte limit the sensor 
performance and their widespread application. This problem is further exacerbated in cases when 
the concentration of target analyte is much smaller than other molecules, leading to almost the 
same magnitude of desired signal (associated with receptor/analyte binding) and noise (associated 
with non-specific binding) from the sensor 51. 
4.3.2 Competition sensing mode 
Two different sensing modes – conventional sensing and the proposed competitive sensing 
mode – are schematically represented in Fig 1.  The conventional mode relies on resolving sensor 
signal associated with formation of affinity complexes between aptamer molecules and target 
analytemolecules on the sensing surface. The proposed “competition” sensing mode relies on 
resolving the surface stress changes associated with release of receptors immobilized on a sensing 





The aptamer release rate may be approximated by modeling the sensor as a spherical cell 
and dividing the volume around the sensor into two discrete compartments, as shown in Fig.4. 2 
72,73. Please note that, the simplifying assumption of spherical geometry and compartment based 
solution are chosen only to demonstrate the essential physics underlying the “competition” sensing 
mode. In the outer compartment of this simple system, the analyte concentration remains same as 
the bulk solution and aptamer concentration is negligibly small. However, in the inner 
compartment enclosing the sensor, the aptamer and analyte concentration changes due to 
  
Concentrations 
away from the 
sensor 
[B] =[BT], [L] = [X] 
= 0 
Sensor 
Figure 4.1 Schematic representation of conventional and competition sensing mode 




binding/unbinding reactions and diffusive transport of aptamer and analyte between the two 
compartments72-75. 
The sensor surface covered with /aptamer complexes at surface coverage density of [CT], 
is introduced into the solution of analyte molecules at concentration of [BT]. The changes in surface 
coverage densities of aptamer complexes [C], and immobilized ligand, [R], due to dissociation of 
aptamer complexes, may be described by: 
𝑑[𝐶]
𝑑𝑡
= 𝑘𝑜𝑛[𝐿][𝑅] − 𝑘𝑜𝑓𝑓[𝐶],     𝑎𝑛𝑑 [𝑅] + [𝐶] = [𝐶𝑇] ,   (2) 
𝑑[𝑅]
𝑑𝑡
= −𝑘𝑜𝑛[𝐿][𝑅] + 𝑘𝑜𝑓𝑓[𝐶],                              (3) 
where, 𝑘𝑜𝑛 and 𝑘𝑜𝑓𝑓 are on- and off-rates of binding between surface immobilized 
ligandand aptamer and are related to aptamer affinity through,𝐾𝑎 =
𝑘𝑜𝑛
𝑘𝑜𝑓𝑓
⁄  ; [L] is the 
concentration of released aptamers. In the absence of analyte, the released aptamer may diffuse 
away from the cantilever surface into the surrounding solution, however in the presence of target 
analyte of concentration [B], the aptamers can either diffuse into the surrounding solution or react 
with analyte forming soluble analyte/aptamer complexes of concentration, [X].  Hence, the aptamer 




= −𝑘𝑜𝑛[𝐿][𝑅] + 𝑘𝑜𝑓𝑓[𝐶] − 𝑉𝑘𝑜𝑛
𝑠 [𝐿][𝐵] + 𝑉𝑘𝑜𝑓𝑓
𝑠 [𝑋] − 𝑘+𝐿[𝐿], (4) 
where 𝑉 is the volume of the compartment surrounding sensor, 𝑘𝑜𝑛
𝑠  and 𝑘𝑜𝑓𝑓
𝑠  are binding 
and unbinding rate constants of aptamer and analyte molecules, 𝑘+𝐿 is the rate constant that 




Similarly, the concentration of the analyte molecules and soluble aptamer/analyte complexes in 





𝑠 [𝐿][𝐵] + 𝑉𝑘𝑜𝑓𝑓





𝑠 [𝐿][𝐵] − 𝑉𝑘𝑜𝑓𝑓
𝑠 [𝑋] − 𝑘+𝑋[𝑋], (6) 
where 𝑘+𝐵 and 𝑘+𝑋 are the rate constants that characterizes diffusion of analyte and soluble 
aptamer/analyte complexes between the inner and outer compartments. The diffusion rate 
constants are approximated using the Smoluchowski’s diffusion limited rate constants72-75. 
The coupled linear differential equations (Eqs (2-6)) were solved for typical values of 
aptamer binding constants and diffusion coefficients to determine the changes in concentrations, 
[L], [B] and [X] as well as the surface coverage [R] and [C] on the sensor73-78.  
The change in surface coverage of analyte aptamer complexes, [C], determines the sensor 
response to different analyte concentrations. However, the surface coverage changes will be 
proportional to the concentration of aptamer/cocaine complexes immobilized on the sensor surface 
and this may change from one experiment to other.  Hence a non-dimensional measure, M of 
coverage change may be obtained by determining the change in coverage from time t1 to t2 
normalized by the average of their sum. 
𝑀(𝑡1, 𝑡2) =  2
𝐶(𝑡1)−𝐶(𝑡2)
𝐶(𝑡1)+𝐶(𝑡2)
                                                                                                           (7) 
The measure, M, or normalized aptamer release for t2 =2t1= 600s, is plotted in Fig 3 for 




relative affinity greater than 1 imply that receptor is more likely to bind the analyte than surface 
site. Hence relative affinity of 100 is utilized to represent the case of specific binding while relative 
affinity of 0.01 is used to represent the nonspecific binding to interfering species. The results for 
conventional sensing mode calculated using equation (1), for similar range of binding affinities 
and concentrations are also plotted in Fig. 3.  
The release rate is strongly dependent on the analyte concentration in case of specifically 
binding species and is not influenced by large concentration changes of interfering species. These 
results suggest that: 1) the sensor response in the competition sensing mode is driven by 
consumption of the receptor by diffusion and specific binding to free analyte; 2) the receptor 
release rate displays a lower detection threshold and a higher sensitivity to specifically binding 
analyte molecules in comparison to the conventional sensing mode; 3) the sensor response in the 
competition sensing mode is insensitive to large changes in concentration change for interfering 
molecules whereas the response in conventional mode is influenced by large concentrations of 
interfering molecules. These results suggest that rate of aptamer release may be used to detect the 













Figure 4.3  Comparison of sensor response for competition sensing mode (solid lines) and 
conventional sensing modes (dashed lines) for molecules with range of binding affinities. Here the 
specific binding affinity of the receptor for analyte is assumed to be 104 times greater than that 





4.4 Experimental results 
4.4.1 Electrochemical experiments with two different surface immobilizations 
(i) Strong immobilization with thrombin 
To test the competition sensing mode, with an electrochemical biosensor, the thrombin 
binding aptamer (15 nucleotide consensus sequence) and human α-thrombin were chosen as the 
receptor and the target analyte respectively. The idea is to exploit the reversible bond between the 
aptamer and α-thrombin where the surface bound complex of the two is exposed to free α-thrombin 
in solution. The aptamer dissociation rate is then monitored to form the sensor response and 
produce the calibration curve against varying concentration of α-thrombin. 
The α-thrombin (1 µM) is attached to a gold coated glass slide through a covalently formed 
SAM layer of 16-mercaptohexadecanoic (MHA) acid activated by treatment with carbodiimide 
(EDC). To further passivate the surface, it is treated with 6-mercaptohxanol (MCH) before 
attaching α-thrombin. Then the protein activated surface is functionalized with 1 µM of thrombin 
binding aptamer. Afterwards, to neutralize any unbound carbodiimide the surface is treated with 
ethanolamine. In between each step the surface is washed in the solvent in which the corresponding 
solution is prepared. 
The gold coated slide is then put into a custom made electrochemical cell, where the slide 
is connected to the working electrode lead of a potentiostat. An Ag/AgCl wire and a Pt wire are 




used as the reference and counter electrode respectively. Ferro/Ferri redox couple in 1X PS buffer 
is used as electrolyte. 
To measure the changes occurring at the surface due to free protein injection, the electrical 
characteristics of the transducer was probed with chronoamperometry and electrochemical 
impedance spectroscopy. Figure 6 shows the schematic of the electrochemical biosensor. 
 
 
Figure 4.5  (A) Step potential for the chronoamperometry (B) Current response from 
chronoamperometry at 1 nM α-thrombin injection into the system (C) electrical circuit 
model of the system (D) Time constant calculated by fitting of the chronoamperometry data 
for α-thrombin and blank injections. 
 
The redox characteristics of the aptamer-thrombin functionalized surface is characterized 
by using cyclic voltammetry. This gives an idea of the reduction/oxidation potentials for the 
functionalized surface. The potential of (+) 120 mV is chosen as the DC excitation potential for 




result are highlighted in figures 7 (A) and 7 (B). The current response for the excitation step 
potential is fitted to the electrochemical model shown in 7 (C) to extract the RC time constant for 
each α-thrombin and blank injections. The time constant is found to increase with α-thrombin 
concentration much appreciably in comparison to any blank injection and shows a saturation 
behavior at the higher concentrations. The RC time constant is a measure of the charging current 
for the double layer on the surface formed by the functionalization. Its change with varying protein 
concentration indicates that the double layer is affected by it, as blank does not produce appreciable 
change. If the aptamer is released from the surface as per the model of competition sensing mode, 
then the double layer will also be affected. This gives a qualitative assessment however it does not 
directly provide the aptamer release rate as the time constant is not directly related to the surface 
coverage. 
On the other hand EIS provides direct data regarding surface coverage as the values of RCT 
(charge transfer resistance) can be calculated from fitting of the data as per the model in 7 (C) 
Figure 4.6 (A) Bode plot (B) Nyquist plot (C) Comparison between direct and competition 
sensing mode for α-thrombin detection. (D) Comparison between the sensor response due to α-




As seen from 8 (C), the normalized sensor response is compared for both direct and 
competition mode of sensing. Both the cases are fitted to a Langmuir isotherm and the KD is 
calculated to be 2.8 nM and 1.4 nM for direct and competition mode respectively. The solution KD 
for this system is about 3 nM. This agrees with figure 5 of the mathematical model for systems 
with relative affinity around 1. Figure 8 (D) shows the response due to negative control γ-thrombin 
and it is observed to give rise to random responses, but of considerable magnitude. 
 (ii) Weak immobilization with linker 
The theory is next tested by using a different attachment scheme where instead of attaching 
the aptamer to the surface bound protein it was attached to a thiolated linker. The linker is chosen 
so that it has a melting temperature low enough and close to experimental conditions, assuming 
that in such a scenario it will form a weak reversible bond with the aptamer. The sequences for the 
aptamer and the linker are shown in figure 4.7. 




The same set of experiments utilizing the EIS technique is conducted for this system and 
the analyzed data is plotted in figure 4.8A in conjunction with the direct sensing as well as the case 
where aptamer was bound to protein on surface (prediction for computation reproduced in figure 
4.8B). It is seen that for the new scenario the sensitivity is higher with the signal saturating faster 
at lower concentrations of alpha thrombin. This follows the hypothesis described before and the 
computational results shown in figure 4.3. It was found that for the case with the weak attachment 
using the linker, the improvement in sensor response was less (2 times at most for some 
concentrations). This is due to the fact that the complex of alpha thrombin and aptamer has about 
the same affinity to the surface attached linker as it is for only the aptamer itself (figure 4.8D). 
Figure 4.8C shows that with time the response due to analyte decreases, which could possibly due 
to re-binding of formed aptamer-thrombin complex to the surface attached linker. Hence, a better 
design of the linker, where the affinity for the aptamer or aptamer-target complex is much lower, 
is required to bring about better response as envisioned by the theoretical analysis. 
 
Figure 4.8 (A) Response for the electrochemical sensor, relative affinity for the two cases 
are shown (B) Computational prediction (C) Response vs time curves for different analyte 
concentration for the weakly bound case (D) Binding curve for aptamer with linker and 




4.4.2 Application of the technique to weakly bound aptamer on microcantilever 
A miniature sensor consisting of two adjacent micro-machined cantilevers (a sensing 
/reference pair) was used for sensing experiments14,77-79 in both conventional and proposed 
competition sensing modes.  The differential surface stress associated with formation or release of 
affinity complexes on the sensing cantilever was measured to determine the sensor response.  A 
novel interferometric technique is used to measure the differential surface stress induced bending 
of the sensing cantilever with respect to the reference cantilever. The principle of differential 
surface stress measurement is schematically presented in Fig. 4 and details of operation are given 
elsewhere 14,77-79.  
The unique advantages of the differential surface stress sensor are: 1) Direct detection of 
differential surface stress eliminates the influence of environmental disturbances such as 
nonspecific adsorption, changes in pH, ionic strength, and temperature; and 2) differential 
interferometry is scalable, which results in the measurement of differential deflections over a large 
area and enables an array of sensors to be easily fabricated on a single device.  
For the conventional sensing mode, one surface of the sensing cantilevers was coated with 
the aptamer. The presence of cocaine molecules was detected by resolving the surface stress 
changes associated with formation of cocaine/aptamer complexes on the sensitized surface. 
Results from conventional sensing mode for different cocaine concentrations are plotted in Fig. 5 
Figure 4.9 Schematic representation of the differential interferometry based 




and show that the sensor response to different concentrations of cocaine molecules follows the 
Langmuir isotherm as shown in Eq. (1).  The low affinity of the aptamer for cocaine limits the 
threshold sensitivity to similar magnitude as reported for other aptasensors77.  
For the “competition” sensing mode, the sensing cantilevers were coated with thiolated 
cocaine and incubated in a cocaine-aptamer solution such that the cocaine/aptamer complexes are 
immobilized on only one side of a microcantilever.  The surface stress change associated with 
formation of the cocaine/aptamer complex induced a large bending of the microcantilever. 
Dissociation of the complexes resulted in relaxation of the surface stress and consequent reduction 
in cantilever bending. During the sensing experiments, the cocaine/aptamer complex coated 
cantilever was introduced into solutions of different cocaine concentrations and the relaxation in 
cantilever bending was monitored to determine the rate of aptamer release from the cantilever 
Figure 4.10 Sensor performance for cocaine detection in PBS 




surface. The measure, M, shown in Eq. (7), was computed for similar time range t2 =2t1= 600s 
from the measured cantilever bending. 
Experimental results for the “competition” sensing mode are also plotted in Fig. 5 and show 
that the measured sensor response is in excellent agreement with the response predicted based on 
the simple compartment analysis shown in Fig. 2. The novel competition sensing mode 
demonstrates a sensing threshold of 100 ng/ml of cocaine concentration in phosphate buffered 
saline solution and achieves the same detection threshold as immunoassays77 but in much shorter 
time of about 10 minutes.  The competition sensing mode results in 20 times increase in sensitivity 
and 15 times lower detection thresholds for sensing of analytes in aqueous solutions compared to 
conventional sensing approach. 
4.5 Conclusion 
A new scheme of sensing is explored, in which the receptor is bound with a linker on the 
surface of the sensor and there is competition in affinities between the linker and receptor and 
receptor and target analyte in the solution surrounding the receptor functionalized surface. 
Computations predict that such an arrangement will produce higher sensitivity and enable better 
signal/noise ratio, for low concentration targets in the presence of interfering molecules. The 
concept was tested using electrochemical experiments for two different scenarios (1) when the 
receptor is strongly bound to the linker and (2) when the receptor is weakly bound to the linker, 
with computations predicting that for case (2) there will be a greater sensitivity. The experiments 
agree quite well with the theory, though experiments with negative controls would determine the 
effects of interfering species on the system. 
The electrochemical biosensor based on the competition mode is far from perfect as it has 




(1) Stabilization of the system before starting each experiment and reduction of 
variability in the starting state. 
(2) The reduction of response due to negative control. 
(3) Utilizing a differently designed linker, such that its affinity to the aptamer is less 
and it can generate a much higher aptamer release rate, thus promoting better signal. 
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5.1 Abstract 
Portable / point-of-care diagnostics is assuming greater relevance and importance in the 
medical healthcare community. These devices will become the ubiquitous components of disaster 
management tools in case of epidemics, pandemics and events of bio-terrorism. In hospital settings 
such sensors can be attached to the patient bed for continuous or intermittent monitoring of certain 
chemicals. In the clinics, they can provide quick analyses for disease / pathogen detection. Cheap, 
portable sensors shall be particularly useful in developing countries and rural communities. In the 
quest for creating such devices an amalgamation of technologies from several scientific disciplines 
like molecular biology, materials science and electrical / computer engineering is required. 
Recently, aptamers have drawn lot of interest over antibodies as recognition elements and for 
several reasons electrochemical biosensors have shown great promise as devices capable of fast, 
accurate and quantitative detection of biological target agents. In this chapter, the development of 
an aptasensor for detection of proteins associated with Ebola virus infection and Acute Kidney 
Injury is described. 






5.2.1 Point-of-care Testing Devices 
The College of American Pathologists describe point-of-care testing (POCT) devices 
capable of performing tests designed to be used at or near the site where the patient is located, that 
do not require permanent dedicated space, and that are performed outside the physical facilities of 
the clinical laboratories. Commonly used POCT devices are blood/sweat glucose measurement 
devices, electrolytes, blood gas analysis, urine dipsticks for pregnancy / creatinine analysis, 
hemoglobin, cardiac markers, bilirubin and strep bacterial analysis. Certain pandemic/endemic 
infectious diseases like HIV and Influenza are also detected using POCT devices. With multiple 
ways of performing the same test standardization/comparability is becoming a critical issue for 
larger systems 1.  
Facilitated by the development in nanotechnology resulting in device miniaturization, big 
data revolution and wireless communication, there will be a dramatic shift in which doctors care 
for patients and the patient participation in their own health care will increase. Health care will 
become more personalized through tailoring of interventions to individual patients. Hopefully, the 
next decade will bring a new realm of precision and efficiency to the way information is 
transmitted and interpreted and thus the way medicine is practiced. Low-cost diagnostic devices 
can be used at the point-of-patient care for disadvantaged and under-served populations in the U.S. 
as well as in the developing world, particularly in remote or rural communities and small hospitals 
that do not have ready access to these technologies. 
In this chapter, the focus is on two different areas of public healthcare : (1) Detection of 
infectious disease (2) Detection/evaluation of pathological ailment. In attaining the objectives, the 





5.2.2 Infectious Disease – Ebola Virus Epidemic 
Ebola virus is a family of zoonotic pathogen, originating from West Africa, which causes 
a very fatal acute hemorrhagic fever called Ebola Virus Disease (EVD) in humans with an average 
fatality case fatality rate varying from 25% to 90% in the past outbreaks 2. The 2014–2016 outbreak 
in West Africa was the largest and most complex Ebola outbreak since its discovery in 1976. It 
engulfed many countries, starting in Guinea then moving across land borders to Sierra Leone, 
Liberia and Nigeria 2 . The Zaire species (EBOV) is the most virulent in the last outbreak, followed 
by the Sudan species (SUDV). As of 1st August 2018, there is another reported outbreak in the 
Eastern Democratic Republic of Congo (https://www.cdc.gov/vhf/ebola/outbreaks/drc/2018-
august.html). The NIAID has classified EBOV as a Category A Priority pathogen whereas the 
CDC has declared it as a Category A Agent of Bioterrorism. The incubation period, that is, the 
time interval from infection with the virus to onset of symptoms is 2 to 21 days. Humans are not 
infectious until they develop symptoms. An early intervention, utilizing improved diagnostic 
devices can thus help in treating the disease and lowering the fatality rates. RT-PCR (Real Time 
Polymerase Chain Reaction) and antibody based ELISA are the two established techniques for 
Ebola virus infection detection which rely on considerable laboratory resource and trained 
personnel. The ReEBOV antigen rapid test 3, 4 has garnered a lot of attention for its use as a viable 
POC diagnostic tool in the field (http://www.who.int/medicines/ebola-
treatment/1st_antigen_RT_Ebola/en/), though it has also drawn some criticism due to doubts on 
reproducibility and specificity 5 (http://somatosphere.net/2018/04/reebov.html). The OraQuick® 
Ebola Rapid Antigen Test which was granted an Emergency Use Authorization (EUA) by the U.S. 
Department of Health and Human Services 6, has been called back by US FDA on issues of stability 
(https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=148583) . Also, all these 




scenarios. Thus, a low cost portable device can help in positively impacting the public health 
outcomes in the under privileged West African countries where the at risk population is generally 
rural 7. 
Studies have shown that there are two key proteins, synthesized by the Ebola virus, called 
Glycoprotein 1,2 (GP 1,2) and soluble Glycoprotein (sGP) which are associated with the attack of 
the Ebola virus on human immune cells, liver cells and endothelial cells of the blood vessels 8, 9. 
GP 1,2 help the virus to enter host cells and sGP is produced by the viral genome because of entry 
and hijacking of host cell machinery. sGP monomers bind to each other in a parallel orientation 
and are linked by two disulfide bonds, at residues Cys53 and Cys306 to form a 110 kDa homodimer 
9-12. It may be noted that a biosensor possessing the ability to detect GP 1,2 / sGP may be used to 
diagnose Ebola infection in humans. 
5.2.3 Pathological Ailment -  Acute Kidney Injury  
Acute kidney failure or injury (AKI) occurs when kidneys suddenly become unable to filter 
waste products from the blood leading to detrimental chemical imbalance in the body. Progression 
towards AKI could be as fast as less than a day and is most common in people who are already 
hospitalized, particularly in critically ill people who need intensive care. It can be fatal and requires 
intensive treatment and is among the top 10 causes of clinical death in the USA 13-16. However, 
AKI may be reversible, through timely diagnosis and medical intervention, and the patient could 
be back to normal or nearly normal kidney function. AKI has been associated with significantly 
increased health care costs and previous studies have shown that median direct hospital costs and 
hospital length of stay were increased by $2,600 and by 5 days, respectively, in patients with AKI 
vs. patients without AKI 14. 
NGAL (also known as Lipocalin-2 or Neutrophil Gelatinase associated Lipocalin) is a 




body. Measurement of urinary NGAL has been demonstrated to be a promising early biomarker 
for AKI due to a variety of reasons like (i) it has a large dynamic range (ii) responds in a dose 
dependent fashion to injury (iii) responds within 3 hours of AKI, which is crucial for emergency 
situations. The high morbidity and mortality of AKI in part shows poor early detection due to the 
lack of a sensitive detection of an associated biomarker and consequent delay in patient care. 
Measuring NGAL in human urine for assessing AKI has been approved in Japan, Korea and parts 
of Europe and is presently being considered by FDA for possible approval in the USA, though 
there are some studies advocating a more cautious approach. Taking all these into account, it also 
has been shown that measuring urinary NGAL in conjunction with serum creatinine provides a 
better and faster assessment of AKI and impending challenges in patient wellbeing. Probably, a 
much more interesting and useful tool would be a cheap, portable platform for measuring serum 
NGAL in conjunction with urine NGAL. To that end it may be noted that commercially available 
quantitative ELISA kits (e.g. Invitrogen TM) can detect NGAL in urine/plasma/serum and culture 
supernatants with a sensitivity of 4 pg/ml i.e. 0.2 pM.  The cost of such a kit is on an average $800 
with the added cost of an ELISA plate reader which can be anywhere between $1000-20,000 
depending on the level of sophistication. These assays can produce results in less than 4 hours. 
Recent studies have put the physiologically critical value of urine NGAL, in relation to AKI, to be 
in the range of 2 – 7 nM.  
5.2.4 Electrochemical Aptasensors : Disease Detection 
Aptamers are nucleic acids that can bind to a wide range of diverse targets, from small 
molecules to proteins and even cells Aptamers offer several advantages over their antibody 
counterparts, including their flexibility to adapt to different assay formats 17. Once aptamers are 
selected (using SELEX) they can be synthesized with high reproducibility and purity and are 




Furthermore, aptamers can be selected against specific regions of targets, which is sometimes 
difficult for antibodies, since the animal-immune system is inherently generated towards specific 
epitopes on target molecules. Aptamers possess excellent selectivity and affinity toward their 
targets, binding with dissociation constants (KD) ranging from picomolar to nanomolar values 
19, 
20. 
Due to advances in nanotechnology and micro-electronics coupled with the revolution in 
big data and wireless communications it is now possible to develop portable and low-cost 
electrochemical biosensors. In particular, impedance spectroscopy based devices can produce 
results in less than 1 hour 21. Such devices are also deemed to be user friendly in a sense that no 
specialized training other than the commonly acquired skill of smartphone operation shall be 
adequate to make use of the biosensor 22. The main issue is the selection of a robust recognition 
element and the transducer interface which can facilitate the sensitive discrimination of target in a 
complex matrix. In chapter 3 the development of an electrochemical aptasensor using a 
nanoporous alumina platform is discussed to detect thrombin in a high albumin background. In the 
present chapter the same platform is utilized to test the detection of (1) Ebola viral protein / virus 
particles and (2) NGAL protein in different media. The end objective is to pave the way for the 
development of protype biosensors having a versatile platform to detect any disease. 
5.3 Methods 
Two different approaches were taken to study the feasibility of a portable electrochemical 
aptasensor : (1) the four-electrode method incorporating a nanoporous alumina membrane, 
described in chapter 3, as the transducer whenever the tests were carried in complex matrices like 
serum or in presence of serum albumin (2) the three-electrode method using a gold coated glass 
slide from Thermo-Fisher Scientific as the transducer to detect Ebola virus particles and check the 




For all experiments, platinum wires and Ag/AgCl electrodes were utilized as counter and 
reference electrodes respectively. In case of the four-electrode method (using nanoporous 
aluminum oxide (NAAO) membrane in the electrochemical cell), platinum wire served the purpose 
of the working electrode whereas the gold coated glass slide was the working electrode for the 
three-electrode method.  
The aptamers were sourced from Aptalogic Inc. and unless otherwise mentioned in the 
results and discussions section, 1X phosphate buffered saline (PBS) or a mixture of 1 X PBS and 
serum / serum albumin was utilized as the electrolyte. A detailed explanation of the methods is 
presented in chapter 3. 
5.4 Results and Discussion 
As the development of a similar sensing scheme for two different diseases have been 
combined in this chapter, the discussion of the findings from the research conducted has been 
demarcated in the subsequent sections. 
In chapter 3, the “single-loop” model, is utilized to process the electrochemical data for 
acquiring sensor parameters like membrane pore resistance, Rpore , and membrane capacitance , 
Cmem. It is noted that when experiments are conducted in presence of serum, or very high albumin, 
it is useful to utilize a “two-loop” model as shown in figure 5.1, having one loop for the reference 
electrodes (electrode resistance Relec, electrode capacitance Celec). Through repeated experiments, 
it was observed that the electrode properties behave randomly and don’t show any discernible 




changes, whereas, Rp changes with target analyte concentration. Cmem changes appreciably only in 
the absence of serum. So Rp is selected as the sensor parameter of interest.  
5.4.1 Ebola Viral Protein Detection 
Aptamer 6011 selected against Ebola viral protein sGP, is a DNA aptamer. It is a thiolated 
aptamer and can thus bind with the gold coated nanoporous alumina oxide (NAAO) membrane. 
All the experiments described in this section are completed in the 4-electrode electrochemical cell. 
Figure 5.2 shows the titration of sGP due to Zaire Ebola virus (EBOV) in both PBS and 10% 
human serum (HS) against aptamer 6011. The calibration curve is shown for the titration done in 
HS. As a negative control, human serum albumin (HSA) was utilized. As discussed in chapter 3, 
with serum, the sensitivity of the lower concentrations of target increases compared to the case 
when only the target is present in the experiment buffer. The KD for the aptamer-sGP complex in 
HS is 2.4 nM, as calculated from the Langmuir fit of the data. It may be noted that HSA titration 
signal is much outside the 95% confidence interval of the predicted calibration curve. 
Figure 5.2 Titration of sGP produced by Zaire (EBOV) Ebola virus against 
aptamer 6011 on the 4-electrode NAAO membrane electrochemical cell is 
shown. The binding was checked in PBS as well as 10% human serum (HS) 




The same aptamer has been shown to bind with sGP produced due to the infection of Sudan 
strain of Ebola virus. The titration against sGP due to the Sudan virus (SUDV) is done in PBS and 
the results are shown in figure 5.3. The KD obtained from the calibration curve using the Langmuir 
fit is 4.5 nM. In comparison to figure 5.2, it may be noted that the saturation signal due to SUD 
sGP (around 25 Ohms) is greater compared to that of EBOV sGP (around 8 Ohms).  
The study was then extended to the detection of sGP in an infected serum. The results of 
the other studies shown in figures 5.2 and 5.3 are from sGP mixed in PBS / HS, which provided 
the calibration data. In the next set of experiments, serum from a monkey infected with Zaire strain 
of Ebola virus i.e. EBOV was tested. For all the experiments the samples were diluted to 10% 
monkey serum (MS). As, the calibration curve for EBOV sGP in uninfected monkey serum (UMS) 
was not available, it was first created, and is shown in figure 5.4 as data from the spiked 
experiments. In comparison with calibration curve of EBOV sGP in HS, as shown in figure 5.2, it 
is very similar. Next, sample dilutions of both the uninfected and infected monkey serum (IMS) 
were made and titrated against aptamer 6011. It may be hypothesized that the sensor signal will be 
Figure 5.3 Titration of sGP produced by Sudan (SUD) Ebola virus 
against aptamer 6011 on the 4-electrode NAAO membrane 




due to the binding between aptamer and sGP as well as due to non-specific interactions between 
aptamer and serum constituents excluding sGP. Hence the signal due to the UMS is subtracted 
from that due to IMS, for each of the dilutions. The results are plotted over the calibration curve 
shown in figure 5.4 
As the dilutions were known, comparison against the calibrated signal values, could help 
predict the actual concentration of EBOV sGP in the IMS. The predicted value of 3.3 ± 0.6 µM 
compares well with ELISA tests predicting a value of 1-3 µM. 
5.4.2 Ebola Virus Particle Detection 
The Ebola virus GP gene encodes two glycoproteins, the major product being the soluble 
dimeric glycoprotein sGP, whereas the minor product is the transmembrane anchored, trimeric 
viral surface glycoprotein (GP). The GP is composed of two parts, GP-1 and GP-2, and is the only 
virally expressed protein on the virion surface and studies have shown that it is critical for 
attachment to host cells and catalysis of membrane fusion. Thus, the GP is a critical component of 
Figure 5.4 The Aptamer 6011 was tested on the NAAO 4-electrode electrochemical cell for 
detection of EBOV sGP in infected monkey serum (MS). Calibration curve was prepared 




vaccines as well as a target of neutralizing antibodies and drugs which inhibit the attachment and 
fusion of virus particles onto the host cells.  
Hence it would be interesting to show if the aptamer 6011 binds with the GP expressed on 
the virion surface, because both sGP and GP have sequence and structural similarity. To test this 
hypothesis, full length virus particles (FLVP) having GP on surface were taken as a positive control 
group and vesicular stomatitis virus (VSV) particles, which don’t have the surface expressed GP, 
were taken as a negative control group. The thiolated aptamer 6011 was attached to a gold coated 
glass slide which was used as the working electrode in a 3-electrode electrochemical cell, 
containing 500 µL of PBS mixed with 1 mM Fe(CN)6
3-/4-. A Pt electrode was used as the counter 
electrode whereas an Ag/AgCl electrode was used as the reference electrode. It was hypothesized 
that in the event of FLVP binding with aptamer 6011, there will be a change in the charge transfer 
resistance (ΔRCT) across the biotic-abiotic interface at the gold coated electrode, as increased steric 
hindrance due to thicker biomolecular layer resulting from the aptamer-FLVP complex will affect 
the oxidation/reduction of Fe(CN)6
3-/4-. As expected, there was a much greater ΔRCT for an 
injection of about 4 x 103 FLVP / µL of injected solution compared to the much lower response 
due to VSV particles having similar concentration, over a time interval of 150 minutes. This 
Figure 5.5 Aptamer 6011 can discriminate between FLVP having surface expressed GP 
against the negative control VSV particle. A 3-electrode electrochemical cell with a gold 




experiment shows that the aptamer 6011 is capable of binding to GP expressed on the surface of 
virion. 
5.4.3 Comparison between Ebola Detection Schemes 
Table 5.3 Ebola Virus Sensors 
Sl. 
No. 
Reference Method Transducer / Target Detection limit Time 





based nanozyme / 
Zaire GP 
2 nM in diluted 
serum 
30 mins 
2 Yen et al. 24, 
2015 
Chromatography Nitrocellulose 
membrane / Zaire GP 
2.7 nM in blood, 
plasma 
 
3 Daaboul et al. 
25, 2014 
Optical / single 
particle interferometry 




5 × 103 pfu/ml 
blood, plasma 
2 hours 






106 pfu/ml in PBS 90 mins 
4 Cai et al. 27, 
2015 
Opto-fluidic Molecular beacon, 
fluorescence / Ebola 
RNA 
0.2 pfu/ml in water 3-10 mins 
5 Chen et al. 28, 
2017 
Electrochemical FET Antibody on 
alumina/graphene 
oxide / Zaire GP 
18 pM in 1% 
serum 
Few seconds 
6 ReEBOVTM Chromatography / 
LFA 
VP40 11.4 nM in blood 15 mins for 
qualitative 








LAMP) of the 
glycoprotein gene 






8 This work Electrochemical 
impedance 
Aptamer on 
nanoporous alumina / 
sGP and virus particles 
2 nM in 10% 
serum 
2-3 hours for 
quantitative / 
30 mins for 
qualitative 
 
Table 5.1 shows the comparison between the results of the present work and a handful of 
the POC sensors for Ebola infection as reported in the literature. It may be observed that most of 
the reported sensors either detect GP or virus particles. The work described in this study could 
arguably be the first to detect sGP which is found in abundance in the blood of an infected 
individual. In case of a qualitative (YES/NO) type sensor, the sensing mechanism can produce 




in 3 hours ( EIS scans of six different dilutions of the sample to compare against a standard 
calibration curve). In addition, our work is also able to detect GP expressed on the surface of virus 
particles, which may have potential therapeutic applications. 
5.4.4 NGAL Detection  
The RNA aptamer 3832 selected to bind with NGAL, the biomarker for AKI, was tested 
in the 4-electrode electrochemical cell. The gold coated nanoporous alumina membrane was firstly 
functionalized against a linker oligonucleotide. Then the aptamer 3832 was let to hybridize by 
forming the receptor on the transducer; following passivation with mercaptohexanol, the 
functionalized membrane is put into the electrochemical cell. NGAL was obtained in recombinant 
form and glycosylated as this modification is present in the physiological form. This variant is 
called rgNGAL. Titration experiments were conducted in SELX buffer ( for all practical purposes 
it is same as PBS) and the results are shown in figure 5.6. The KD obtained from the Langmuir fit 
of the titration data is 75 nM.  
Figure 5.6 The titration of rgNGAL against aptamer 3832 in the NAAO 




To get the sensor response in minimum detection time is essential in POC context as the 
emphasis is on rapid assay. In chapter 3, it has been discussed that Rp and Cmem were combined for 
a particular frequency to get membrane impedance Zmem. In chapter 6 it is further discussed that 
this frequency may be called the optimal frequency for the aptamer-target complex, and impedance 
change is most sensitive at that frequency. It was also noticed that the solution resistance does not 
affect the system response and hence entire system impedance Z at optimal frequency ( discussed 
in chapter 6 ) may be considered as the sensor signal, which can save time spent in analyzing the 
individual components. Hence, this concept is tested for detection of NGAL in presence of HSA 
or HS. Figure 5.7 shows an experiment where aptamer 3832 is tested for its response to HSA 
injections in presence of 64 µM HSA in SELEX buffer over a time of 3 hours and there is very 
negligible response in the system impedance Z, as denoted by the green circles. However, there is 
appreciable response / signal when certain concentrations of rgNGAL is injected into the system, 
as denoted by the red circles. 
Figure 5.7 rgNGAL injections produce appreciable signal in 
presence of high HSA background in the 4-electrode 
electrocehmical cell having NAAO membrane functionalized 




The aptamer 3832 is modified by thiolating a certain portion of the oligonucleotide 
sequence such that it can bind directly with gold coated NAAO instead of hybridizing with 
thiolated linker thus minimizing sample preparation step. This modified NGAL aptamer is named 
as 37NGAL1A and one experiment was carried out to detect its binding to rgNGAL in presence 
of 10% HS. The results from the titration is shown in figure 5.8 and it is seen that the signal has 
reached saturation. Thus, it is inferred that experiments testing sensor response to lower 
concentrations of rgNGAL are to be done for creating a calibration curve. 
Figure 5.8 rgNGAL titration using thiolated aptamer 37NGAL1A in 10% HS using NAAO 
membrane 4-electrode electrochemical cell 
Figure 5.9 rgNGAL titration using aptamer 3832 in SELEX buffer using a 3-electrode 




The binding of aptamer 3832 to rgNGAL in SELEX buffer was also checked using a gold 
coated glass slide in the 3-electrode electrochemical cell as reported in figure 5.9. This experiment 
was conducted to test the hypothesis that KD is lower when the aptamer is attached to surface in 
comparison to that obtained when the aptamer is in solution. The KD obtained from the Langmuir 
fit of the data shown in figure 5.9 is about 10 nM which is significantly lower than the value of 
200 nM for the same complex in solution as reported from other experiments. 
5.4.5 Comparison between NGAL Detection Schemes 
Table 5.4 Different NGAL biosensors 
Sl. 
No. 
Reference Method Transducer  Detection limit Time 
1 Abbas et al. 
30, 2013 




13 nM in PBS  





polymeric dendrimer on 
gold electrode 
280 pM in PBS  
3 Li et al. 32, 
2015 
Photoelectrochemical Biotinylated nanobody on 
ITO 
0.3 pM in PBS  






1 nM in urine 30 mins 
4 Invitrogen 
ELISATM 
ELISA / plate reader ELISA plate 2 nM in serum 
0.2 pM in urine 
4 hours 
7 This work Electrochemical impedance Aptamer on nanoporous 
alumina  
50 nM in 10% 
serum 
3 hours for 
quantitative / 
30 mins for 
qualitative  
 
The comparison of the sensing capacity between the standard NGAL assays, as well as 
those reported in recent literature and the study presented in this chapter is compared in Table 5.2. 
The physiologically relevant value for NGAL in serum is 7 nM and the sensor described here can 
confidently detect 50 nM in 10% HS. However, lower concentrations of rgNGAL were not tested. 






In this chapter the detection of sGP/virus particles having GP on surface as well as NGAL 
were detected using an aptamer modified nanoporous alumina membrane as transducer for a 4-
electrode electrochemical cell, to establish a proof of concept towards development of portable 
biosensors to diagnose Ebola virus infection and Acute Kidney Injury respectively. It is shown 
that the detection of the biomarkers is better when the system is having a background of human 
serum albumin / human serum and this is beneficial as patient sampled will not need to be 
processed to remove interfering molecules except blood corpuscles. It was shown that the pore 
resistance Rp is a good parameter to choose as sensor signal, however if the optimal frequency of 
the system is determined then the system impedance at that frequency may also be used as the 
sensor signal which can reduce the time of operation. The Ebola sensor compares well with 
reported literature on the subject and could predict the amount of sGP in a sample from an Ebola 
infected monkey. The preliminary results from the NGAL sensor is encouraging and more 







1. Coarsey, C. T.;  Esiobu, N.;  Narayanan, R.;  Pavlovic, M.;  Shafiee, H.; Asghar, W., Strategies 
in Ebola virus disease (EVD) diagnostics at the point of care. Critical Reviews in Microbiology 
2017, 43 (6), 779-798. 
 
2. Baize, S.;  Pannetier, D.;  Oestereich, L.;  Rieger, T.;  Koivogui, L.;  Magassouba, N. F.;  
Soropogui, B.;  Sow, M. S.;  Keïta, S.;  De Clerck, H.;  Tiffany, A.;  Dominguez, G.;  Loua, M.;  
Traoré, A.;  Kolié, M.;  Malano, E. R.;  Heleze, E.;  Bocquin, A.;  Mély, S.;  Raoul, H.;  Caro, 
V.;  Cadar, D.;  Gabriel, M.;  Pahlmann, M.;  Tappe, D.;  Schmidt-Chanasit, J.;  Impouma, B.;  
Diallo, A. K.;  Formenty, P.;  Van Herp, M.; Günther, S., Emergence of Zaire Ebola Virus 
Disease in Guinea. New England Journal of Medicine 2014, 371 (15), 1418-1425. 
 
3. Cross, R. W.;  Boisen, M. L.;  Millett, M. M.;  Nelson, D. S.;  Oottamasathien, D.;  Hartnett, J. 
N.;  Jones, A. B.;  Goba, A.;  Momoh, M.;  Fullah, M.;  Bornholdt, Z. A.;  Fusco, M. L.;  Abelson, 
D. M.;  Oda, S.;  Brown, B. L.;  Pham, H.;  Rowland, M. M.;  Agans, K. N.;  Geisbert, J. B.;  
Heinrich, M. L.;  Kulakosky, P. C.;  Shaffer, J. G.;  Schieffelin, J. S.;  Kargbo, B.;  Gbetuwa, 
M.;  Gevao, S. M.;  Wilson, R. B.;  Saphire, E. O.;  Pitts, K. R.;  Khan, S. H.;  Grant, D. S.;  
Geisbert, T. W.;  Branco, L. M.; Garry, R. F., Analytical Validation of the ReEBOV Antigen 
Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. The Journal of Infectious 
Diseases 2016, 214 (suppl_3), S210-S217. 
 
4. Broadhurst, M. J.;  Kelly, J. D.;  Miller, A.;  Semper, A.;  Bailey, D.;  Groppelli, E.;  Simpson, 
A.;  Brooks, T.;  Hula, S.;  Nyoni, W.;  Sankoh, A. B.;  Kanu, S.;  Jalloh, A.;  Ton, Q.;  Sarchet, 
N.;  George, P.;  Perkins, M. D.;  Wonderly, B.;  Murray, M.; Pollock, N. R., ReEBOV Antigen 
Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field 
validation study. The Lancet 2015, 386 (9996), 867-874. 
 
5. Broadhurst, M. J.;  Semper, A.;  Bailey, D.; Pollock, N. R., ReEBOV Antigen Rapid Test kit 
for Ebola – Authors' reply. The Lancet 2015, 386 (10010), 2255-2256. 
 
 
6. VanSteelandt, A.;  Aho, J.;  Franklin, K.;  Likofata, J.;  Kamgang, J. B.;  Keita, S.;  Koivogui, 
L.;  Magassouba, N. F.;  Martel, L. D.; Dahourou, A. G., Operational evaluation of rapid 
diagnostic testing for Ebola Virus Disease in Guinean laboratories. PLoS ONE 2017, 12 (11), 
e0188047. 
 
7. Kaushik, A.;  Tiwari, S.;  Dev Jayant, R.;  Marty, A.; Nair, M., Towards detection and diagnosis 
of Ebola virus disease at point-of-care. Biosensors and Bioelectronics 2016, 75, 254-272. 
 
8. Bradley, J. H.;  Harrison, A.;  Corey, A.;  Gentry, N.; Gregg, R. K., Ebola virus secreted 
glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory 





9. de La Vega, M.-A.;  Wong, G.;  Kobinger, G. P.; Qiu, X., The Multiple Roles of sGP in Ebola 
Pathogenesis. Viral Immunology 2015, 28 (1), 3-9. 
 
10. Mohan, G. S.;  Ye, L.;  Li, W.;  Monteiro, A.;  Lin, X.;  Sapkota, B.;  Pollack, B. P.;  Compans, 
R. W.; Yang, C., Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate 
Virus Production and Infectivity. Journal of Virology 2015, 89 (2), 1205. 
 
11. Wahl-Jensen, V.;  Kurz, S. K.;  Hazelton, P. R.;  Schnittler, H.-J.;  Ströher, U.;  Burton, D. R.; 
Feldmann, H., Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in 
Activation of Human Macrophages. Journal of Virology 2005, 79 (4), 2413. 
 
12. Noda, T.;  Sagara, H.;  Suzuki, E.;  Takada, A.;  Kida, H.; Kawaoka, Y., Ebola Virus VP40 
Drives the Formation of Virus-Like Filamentous Particles Along with GP. Journal of Virology 
2002, 76 (10), 4855. 
 
13. Askenazi, D. J.;  Ambalavanan, N.; Goldstein, S. L., Acute kidney injury in critically ill 
newborns: What do we know? What do we need to learn? Pediatric Nephrology 2008, 24 (2), 
265. 
 
14. Parikh, A.;  Rizzo, J. A.;  Canetta, P.;  Forster, C.;  Sise, M.;  Maarouf, O.;  Singer, E.;  Elger, 
A.;  Elitok, S.;  Schmidt-Ott, K.;  Barasch, J.; Nickolas, T. L., Does NGAL reduce costs? A cost 
analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) 
diagnosis. PLOS ONE 2017, 12 (5), e0178091. 
 
15. Ribitsch, W.;  Schilcher, G.;  Quehenberger, F.;  Pilz, S.;  Portugaller, R. H.;  Truschnig-
Wilders, M.;  Zweiker, R.;  Brodmann, M.;  Stiegler, P.;  Rosenkranz, A. R.;  Pickering, J. W.; 
Horina, J. H., Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of 
contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study). Scientific 
Reports 2017, 7, 41300. 
 
16. Ronco, C., Biomarkers for acute kidney injury: is NGAL ready for clinical use? Critical Care 
2014, 18 (6), 680. 
 
17. Tasset, D. M.;  Kubik, M. F.; Steiner, W., Oligonucleotide inhibitors of human thrombin that 
bind distinct epitopes. Journal of Molecular Biology 1997, 272 (5), 688-698. 
 
18. Ilgu, M.; Nilsen-Hamilton, M., Aptamers in analytics. Analyst 2016, 141 (5), 1551-1568. 
 
19. Deng, B.;  Lin, Y.;  Wang, C.;  Li, F.;  Wang, Z.;  Zhang, H.;  Li, X.-F.; Le, X. C., Aptamer 
binding assays for proteins: The thrombin example—A review. Analytica Chimica Acta 2014, 





20. Hermann, T.; Patel, D. J., Biochemistry - Adaptive recognition by nucleic acid aptamers. 
Science 2000, 287 (5454), 820-825. 
 
21. Grieshaber, D.;  MacKenzie, R.;  Vörös, J.; Reimhult, E., Electrochemical Biosensors - Sensor 
Principles and Architectures. Sensors 2008, 8 (3). 
 
22. Sun, A.;  Wambach, T.;  Venkatesh, A. G.; Hall, D. A. In A low-cost smartphone-based 
electrochemical biosensor for point-of-care diagnostics, 2014 IEEE Biomedical Circuits and 
Systems Conference (BioCAS) Proceedings, 22-24 Oct. 2014; 2014; pp 312-315. 
 
23. Duan, D.;  Fan, K.;  Zhang, D.;  Tan, S.;  Liang, M.;  Liu, Y.;  Zhang, J.;  Zhang, P.;  Liu, W.;  
Qiu, X.;  Kobinger, G. P.;  Fu Gao, G.; Yan, X., Nanozyme-strip for rapid local diagnosis of 
Ebola. Biosensors and Bioelectronics 2015, 74, 134-141. 
 
24. Yen, C.-W.;  de Puig, H.;  Tam, J. O.;  Gómez-Márquez, J.;  Bosch, I.;  Hamad-Schifferli, K.; 
Gehrke, L., Multicolored silver nanoparticles for multiplexed disease diagnostics: 
distinguishing dengue, yellow fever, and Ebola viruses. Lab on a Chip 2015, 15 (7), 1638-1641. 
 
25. Daaboul, G. G.;  Lopez, C. A.;  Chinnala, J.;  Goldberg, B. B.;  Connor, J. H.; Ünlü, M. S., 
Digital Sensing and Sizing of Vesicular Stomatitis Virus Pseudotypes in Complex Media: A 
Model for Ebola and Marburg Detection. ACS Nano 2014, 8 (6), 6047-6055. 
 
26. Yanik, A. A.;  Huang, M.;  Kamohara, O.;  Artar, A.;  Geisbert, T. W.;  Connor, J. H.; Altug, 
H., An Optofluidic Nanoplasmonic Biosensor for Direct Detection of Live Viruses from 
Biological Media. Nano Letters 2010, 10 (12), 4962-4969. 
 
27. Cai, H.;  Parks, J. W.;  Wall, T. A.;  Stott, M. A.;  Stambaugh, A.;  Alfson, K.;  Griffiths, A.;  
Mathies, R. A.;  Carrion, R.;  Patterson, J. L.;  Hawkins, A. R.; Schmidt, H., Optofluidic analysis 
system for amplification-free, direct detection of Ebola infection. Scientific Reports 2015, 5, 
14494. 
 
28. Chen, Y.;  Ren, R.;  Pu, H.;  Guo, X.;  Chang, J.;  Zhou, G.;  Mao, S.;  Kron, M.; Chen, J., Field-
Effect Transistor Biosensor for Rapid Detection of Ebola Antigen. Scientific Reports 2017, 7 
(1), 10974. 
 
29. Benzine, J. W.;  Brown, K. M.;  Agans, K. N.;  Godiska, R.;  Mire, C. E.;  Gowda, K.;  Converse, 
B.;  Geisbert, T. W.;  Mead, D. A.; Chander, Y., Molecular Diagnostic Field Test for Point-of-
Care Detection of Ebola Virus Directly From Blood. The Journal of Infectious Diseases 2016, 





30. Abbas, A.;  Tian, L.;  Morrissey, J. J.;  Kharasch, E. D.; Singamaneni, S., Hot Spot-Localized 
Artificial Antibodies for Label-Free Plasmonic Biosensing. Advanced functional materials 
2013, 23 (14), 1789-1797. 
 
31. Kannan, P.;  Tiong, H. Y.; Kim, D.-H., Highly sensitive electrochemical determination of 
neutrophil gelatinase-associated lipocalin for acute kidney injury. Biosensors and 
Bioelectronics 2012, 31 (1), 32-36. 
 
32. Li, H.;  Mu, Y.;  Yan, J.;  Cui, D.;  Ou, W.;  Wan, Y.; Liu, S., Label-Free Photoelectrochemical 
Immunosensor for Neutrophil Gelatinase-Associated Lipocalin Based on the Use of 
Nanobodies. Analytical Chemistry 2015, 87 (3), 2007-2015. 
 
33. Yukird, J.;  Wongtangprasert, T.;  Rangkupan, R.;  Chailapakul, O.;  Pisitkun, T.; Rodthongkum, 
N., Label-free immunosensor based on graphene/polyaniline nanocomposite for neutrophil 




CHAPTER 6.  GENERAL CONCLUSIONS  
6.1 Summarizing Conclusions 
In the preceding chapters of the thesis the research problem has been identified and certain 
focus areas and progress made to address the problems in these areas have been described. The 
overarching theme of the thesis is to push the boundaries of the knowledge base of biosensors. The 
field is very vast and demands the confluence of seemingly incongruent fields of molecular 
biology, nanoscience, electrical engineering and electronics, mechanics, materials science, 
biophysics and chemical sciences like electrochemistry. In fact, the discipline of translational 
healthcare requires an amalgamation of such disciplines to provide solutions to emerging and 
intractable problems of public health. In that regard, portable diagnostic systems / point-of-care 
(POC) devices are the need of the hour to determine rapid and accurate detection of severe/chronic 
health conditions, infectious diseases which threaten to become epidemics or global pandemics. In 
chapter 1, the research problem is identified as engineering of the nano-bio interface of the 
transducer in a biosensor, investigation of which can make possible the detection of low 
concentration target analytes in complex medium of the sample containing several interfering 
species, with greater specificity, selectivity and sensitivity. The research described in the different 
chapters of this thesis tries to address with an aim of exploring and providing solutions for the 
development of improved biosensing techniques and devices. 
In chapter 2, it was discussed that electrical actuation of thrombin-aptamer complex is 
possible, where the aptamer is attached to a surface on which certain positive potential is applied. 
It was shown that these positive potentials could overcome the negative screening charges due to 
the oligonucleotide backbone and produce a repulsive force for the dissociation of the positively 




nucleotide sequence as well as the surface grafting density. Particularly grafting densities of 1011 
molecules .cm-2 of electrode surface and 10-30 oligonucleotide lengths are predicted to produce 
best actuation. Negative potentials failed to disrupt the binding mode of the thrombin with the 
aptamer, however, very high positive/negative potentials may destroy the surface. This knowledge 
may be useful in the development of controllable biotic-abiotic interfaces, modulation of ionic 
flow across biomolecular gates which can have potential therapeutic/filtration applications. 
Chapter 3 describes the development of a portable electrochemical biosensor utilizing 
aptamers as recognition elements/receptors. As a transducer, a nanoporous alumina membrane, 
with one side coated with a thin film of gold, was utilized on which the aptamers are grafted. The 
electrochemical biosensor operates on the principle of four-electrode system, in which the 
membrane is situated between two chambers containing the reference electrodes which measure 
the impedance change due to target binding with the aptamers on the membrane surface. To 
calculate the impedance a technique called electrochemical impedance spectroscopy was utilized. 
As a test, the thrombin binding aptamer was used. It was observed that the results improved with 
high concentration of albumin in the background on top of target present in the electrolyte. This 
improved the signal/noise ratio for detection of low concentration targets. The exact mechanism 
behind this phenomenon is not clear, however it is hypothesized that charge accumulation due to 
binding of thrombin on the surface grafted aptamer is changing the flow of ions through the 
nanoporous membrane along with some interaction of the aptamer and the background serum 
albumin. 
In chapter 4, a new scheme of sensing is explored, in which the receptor is bound with a 
linker on the surface of the sensor and there is competition in affinities between the linker and 




surface. Computations predict that such an arrangement will produce higher sensitivity and enable 
better signal/noise ratio, for low concentration targets in the presence of interfering molecules. The 
concept was tested using electrochemical experiments for two different scenarios (1) when the 
receptor is strongly bound to the linker and (2) when the receptor is weakly bound to the linker, 
with computations predicting that for case (2) there will be a greater sensitivity. The experiments 
agree quite well with the theory, though experiments with negative controls would determine the 
effects of interfering species on the system. 
Chapter 5 deals with the application of the proof-of-concept biosensor developed in chapter 
3 for detecting the following biomarkers (1) Ebola viral protein sGP associated with Ebola virus 
infection and (2) NGAL protein, which is being recognized as a biomarker for Acute Kidney 
Injury. The sensor used a DNA aptamer for the Ebola project and an RNA aptamer for the NGAL 
project. The sensor was shown to be able to detect sGP produced by Zaire and Sudan strains of 
Ebola virus and could predict the concentration of sGP in an infected monkey serum in comparison 
to ELISA. The sensor also demonstrated the detection of NGAL using the RNA aptamer designed 
to bind with NGAL in presence of serum albumin as well as human serum. More tests are required 
to be done to create a calibration curve for detecting NGAL in human serum before the sensor is 
utilized to predict concentrations in random samples. As demonstrated in chapter 3, the sensitivity 
of the sensor increases in presence of serum albumin for all scenarios. Also, it was observed in all 
these studies that the most sensitive determination can be made if the optimal frequency of the 
system is known for which the impedance spectroscopy scan is conducted. Looking at variation in 
system impedance for only optimal frequency can help in reducing the time of operation which 
will be beneficial for rapid diagnostic assays. A discussion on optimal frequency is presented in 




6.2 Future Directions 1 : Portable Sensor 
(this work was done with Khang Vu, 2018 REU intern) 
6.2.1 Introduction 
Point of care diagnostics using portable biosensing devices can improve public health by 
reducing patient treatment time and cost. Often these devices are based on electrochemistry and in 
labs are tested using expensive commercial potentiostat. This signal takes the form of an 
impedance due to the electrochemical process. The main limitations of using the prevalent bio-
impedance measurement device , for e.g. the “Gamry Reference 3000 Potentiostat/Galvanostat” is 
price ($15k), as well as the use of a wired connection to a PC and power supply. The main objective 
of this project is to construct an alternative which can replicate the functions of the “Gamry 
Reference 3000” and be cheaper to construct as well as having a small form factor and being 
portable. An attractive solution is the AD5933 network impedance analyzer chip. The chip, 
mounted on a Pmod IA board, will be used to measure the impedance. 
6.2.2 Materials and methods 
The core components of the instrumentation are an AD5933 and an Arduino Uno R3 
Microcontroller. The AD5933 is a complex impedance measurement system that combines an on-
board frequency generator with a 12-bit, 1 MSPS, analog-to-digital converter (ADC). The Arduino 






Uno is used to interface between the end user and the AD5933 and to control various other parts 
of the sensor. Due to the electrochemical nature of the sensor, a 4-electrode setup is preferred. The 
AD5933 chip only supports 2 electrode, however an extension circuit can be constructed to adapt 
to a 4-electrode setup 1-3. 
Other modules that are to be added is a 9V battery power supply for the Arduino, SD card 
module, and Bluetooth shield. These components are aimed at making the device portable. The 
components are on a surface mount standard, so a custom made printed circuit board is kept in 
mind for the final product. For prototyping and testing however, a breadboard will be used, so the 
components will be mounted on breadboard adapters. 
The device is to first be constructed with components necessary to carry out the impedance 
measurement. It will be tested on a “dummy circuit”, a circuit which behaves like the membrane, 
to determine performance. Then it will be tested in an actual experiment with the membrane alone 
and with the presence of proteins. The performance of the sensor will be tested against the 
potentiostat to verify accuracy.  
Once the device has been determined to perform as well as the potentiostat to a reasonable 
degree, the other components will be integrated. The components will also be integrated into a 
printed circuit board. The board will be tested again to ensure no defects occurred during the 






fabrication. The final product will be housed in a compact packaging that can be clipped on the 
belt or carried with relative ease. 
6.2.3 Results and discussion 
Constructing the board had many issues at first. The surface mount standard of the 
components was not initially anticipated. An alternative was found, the Pmod IA Impedance 
Analyzer. The Pmod IA was a circuit board that incorporated the AD5933 chip on an integrated 
circuit board that could much more easily interface with the breadboard and the Arduino. Another 
unforeseen circumstance was the lack of documentation on how to have an Arduino interface with 
an AD5933. Though other research groups have used the AD5933 and Arduino combination, there 
is a lack of documentation on how they were able to interface between the two. There exists a few 
Arduino libraries that claim to be able to interface the two, and fortunately one managed to work 
with the setup. Even with the proper interfacing, there were many obstacles in attempting to 
program the AD5933 properly, such as the Arduino library having outdated documentation 
programs and functions.  
Once interfacing issues were sorted out, the device was first tested on simple resistive 
loads, and the results of the frequency sweep, averaged over 10 iterations, were performed. The 
sensor showed relative accuracy across the frequency sweep (10 to 100 kHz). However, the 
preferred frequency range to be swept is outside what the AD5933 chip is capable of (50-100 Hz). 
Per the AD5933 evaluation board datasheet, the internal clock which runs at 16 MHz, must be 
lowered to measure frequencies in the range desired. To do this with the Pmod IA, a crystal 
oscillator of frequency 100 kHz is required. However as of writing the main vendors of such 




Further tests and measurements were taken on a dummy circuit, and the sensor showed 
positive results, and testing has now moved to the membrane. Membrane tests showed that the 
sensor had drift, which was concluded to be from the experimental setup. To mitigate, the sensor 
was moved and is now housed inside a faraday cage to prevent external noise from interfering.  
 
A Thrombin experiment, where thrombin was added in incremental concentrations in the 
order of nanomolars was performed with the sensor and the potentiostat. Data of both the 
alternative and the commercial potentiostat are then compared, as shown in figures 6.3 and 6.4. 
The findings are that the alternative behaves similarly to the commercial potentiostat. 
  




6.3 Future Directions 2 : Optimal Frequency 
 
In the different systems utilized for the electrochemical biosensors development, namely 
the 3-electrode system (figure 6.5) using the gold coated glass slide as well as the 4-electrode 
system (figure 6.6) having the nanoporous alumina transducer, it is observed that the impedance 
response of the system has few inflection points for the range of frequencies scanned. At those 
inflection points, minima or maxima of the phase can be observed. Out of this observation, of late 
there has been a discussion of an optimal frequency in the literature 4, 5. 
It is hypothesized that if the system impedance is monitored only at this particular 
frequency then the maximum change can be captured in minimum amount of time, instead of 
scanning through multiple frequencies while doing the impedance spectroscopy. 
  
Figure 6.5 Optimal frequency for different aptamer-target complexes where the aptamer is 




This technique may be applied to all the electrochemical experiments and this could make 
rapid diagnostics possible in electrochemical impedance spectroscopy based portable biosensors. 
The receptor-target complex is thus observed to have an optimal frequency where the phase 
response to impedance spectroscopy has a global minimum. It was also found out that the 
impedance change at this frequency is the maximum (sensor response) and thus scanning at this 
frequency will save the time of operation spent in scanning all the frequencies during the 
spectroscopy. It will be of use to determine a mechanistic model for the bimolecular complex by 
taking into account the mass, charge and dielectric properties of these molecules which can affect 
the optimal frequency. This can help in the design of optimized receptors and thus improve 
biosensor performance. 
  
Figure 6.6 Optimal frequency for aptamer 6011 - Zaire sGP complex in different media for 
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